BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27-39. [PMID: 15621988 DOI: 10.1097/01.sla.0000149300.28588.23] [Cited by in Crossref: 405] [Cited by in F6Publishing: 381] [Article Influence: 25.3] [Reference Citation Analysis]
Number Citing Articles
1 Suzuki S, Sasajima K, Sato Y, Watanabe H, Matsutani T, Iida S, Hosone M, Tsukui T, Maeda S, Shimizu K. MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer. Br J Cancer. 2008;99:350-356. [PMID: 18594524 DOI: 10.1038/sj.bjc.6604476] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
2 Yang G, Song J-, Li Y, Gong S-. Under hypoxia conditions contactin-1 regulates the migration of Mkn45 cells through the RhoA pathway. Mol Biol 2015;49:112-9. [DOI: 10.1134/s0026893315010185] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Ozcan S, Barkauskas DA, Renee Ruhaak L, Torres J, Cooke CL, An HJ, Hua S, Williams CC, Dimapasoc LM, Han Kim J. Serum glycan signatures of gastric cancer. Cancer Prev Res (Phila). 2014;7:226-235. [PMID: 24327722 DOI: 10.1158/1940-6207.capr-13-0235] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
4 Solanki S, Chakinala RC, Haq KF, Khan MA, Kifayat A, Linder K, Khan Z, Mansuri U, Haq KS, Nabors C, Aronow WS. Inpatient burden of gastric cancer in the United States. Ann Transl Med 2019;7:772. [PMID: 32042788 DOI: 10.21037/atm.2019.11.54] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
5 Adler AC, Cestero C, Lewis EH 3rd, Roberts IM, Castillo EA. Composite adenocarcinoma and carcinoid gastric tumor in chronic atrophic gastritis and pernicious anemia. Case Rep Gastroenterol 2011;5:232-8. [PMID: 21552452 DOI: 10.1159/000327986] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
6 Han XD, Liu C, Liu F, Xie QH, Liu TL, Guo XY, Xu XX, Yang X, Zhu H, Yang Z. 64Cu-PSMA-617: A novel PSMA-targeted radio-tracer for PET imaging in gastric adenocarcinoma xenografted mice model. Oncotarget 2017;8:74159-69. [PMID: 29088775 DOI: 10.18632/oncotarget.18276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
7 Wesołowska M, Pawlik P, Jagodziński P. The clinicopathologic significance of estrogen receptors in human gastric carcinoma. Biomedicine & Pharmacotherapy 2016;83:314-22. [DOI: 10.1016/j.biopha.2016.06.048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
8 Asombang AW, Rahman R, Ibdah JA. Gastric cancer in Africa: Current management and outcomes. World J Gastroenterol 2014; 20(14): 3875-3879 [PMID: 24833842 DOI: 10.3748/wjg.v20.i14.3875] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
9 Shen JY, Kim S, Cheong JH, Kim YI, Hyung WJ, Choi WH, Choi SH, Wang LB, Noh SH. The impact of total retrieved lymph nodes on staging and survival of patients with pT3 gastric cancer. Cancer 2007;110:745-51. [PMID: 17614104 DOI: 10.1002/cncr.22837] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
10 Nagpal P, Prakash A, Pradhan G, Vidholia A, Nagpal N, Saboo SS, Kuehn DM, Khandelwal A. MDCT imaging of the stomach: advances and applications. Br J Radiol 2017;90:20160412. [PMID: 27785936 DOI: 10.1259/bjr.20160412] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhou WH, Tang F, Xu J, Wu X, Yang SB, Feng ZY, Ding YG, Wan XB, Guan Z, Li HG. Low expression of Beclin 1, associated with high Bcl-xL, predicts a malignant phenotype and poor prognosis of gastric cancer. Autophagy. 2012;8:389-400. [PMID: 22240664 DOI: 10.4161/auto.18641] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
12 Alén BO, Leal-López S, Alén MO, Viaño P, García-Castro V, Mosteiro CS, Beiras A, Casanueva FF, Gallego R, García-Caballero T, Camiña JP, Pazos Y. The role of the obestatin/GPR39 system in human gastric adenocarcinomas. Oncotarget 2016;7:5957-71. [PMID: 26716511 DOI: 10.18632/oncotarget.6718] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
13 Kulig J, Popiela T, Kolodziejczyk P, Sierzega M, Jedrys J, Szczepanik AM. Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients. Langenbecks Arch Surg. 2008;393:37-43. [PMID: 17618451 DOI: 10.1007/s00423-007-0208-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
14 Han X, Li H, Su L, Zhu W, Xu W, Li K, Zhao Q, Yang H, Liu H. Effect of celecoxib plus standard chemotherapy on serum levels of vascular endothelial growth factor and cyclooxygenase-2 in patients with gastric cancer. Biomed Rep 2014;2:183-7. [PMID: 24649093 DOI: 10.3892/br.2013.209] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
15 Hong HN, Won YJ, Shim JH, Kim HJ, Han SH, Kim BS, Kim HS. Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner. J Cancer Res Clin Oncol 2018;144:1649-63. [PMID: 29948146 DOI: 10.1007/s00432-018-2683-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
16 Sianesi M, Bezer L, Del Rio P, Dell’Abate P, Iapichino G, Soliani P, Tacci S. The node ratio as prognostic factor after curative resection for gastric cancer. J Gastrointest Surg. 2010;14:614-619. [PMID: 20101526 DOI: 10.1007/s11605-009-1142-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
17 Chen H, Dai G, Cai Y, Gong Q, Wu W, Gao M, Fei Z. Vasodilator-stimulated phosphoprotein (VASP), a novel target of miR-4455, promotes gastric cancer cell proliferation, migration, and invasion, through activating the PI3K/AKT signaling pathway. Cancer Cell Int 2018;18:97. [PMID: 30002604 DOI: 10.1186/s12935-018-0573-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
18 Haverkamp L, Brenkman HJ, Seesing MF, Gisbertz SS, van Berge Henegouwen MI, Luyer MD, Nieuwenhuijzen GA, Wijnhoven BP, van Lanschot JJ, de Steur WO. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer. 2015;15:556. [PMID: 26219670 DOI: 10.1186/s12885-015-1551-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 9.2] [Reference Citation Analysis]
19 Krzysiek-Maczka G, Wrobel T, Targosz A, Szczyrk U, Strzalka M, Ptak-Belowska A, Czyz J, Brzozowski T. Helicobacter pylori-activated gastric fibroblasts induce epithelial-mesenchymal transition of gastric epithelial cells in vitro in a TGF-β-dependent manner. Helicobacter 2019;24:e12653. [PMID: 31411795 DOI: 10.1111/hel.12653] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Carrillo E, Navarro SA, Ramírez A, García MÁ, Griñán-Lisón C, Perán M, Marchal JA. 5-Fluorouracil derivatives: a patent review (2012 - 2014). Expert Opin Ther Pat 2015;25:1131-44. [PMID: 26165922 DOI: 10.1517/13543776.2015.1056736] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
21 Messager M, Neofytou K, Chaudry MA, Allum WH. Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients. Eur J Surg Oncol 2015;41:1316-23. [PMID: 26166786 DOI: 10.1016/j.ejso.2015.06.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
22 Ueda K, Iwahashi M, Nakamori M, Nakamura M, Naka T, Ishida K, Ojima T, Yamaue H. Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer. Langenbecks Arch Surg. 2009;394:647-653. [PMID: 18343941 DOI: 10.1007/s00423-008-0311-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
23 Oñate-Ocaña LF, Alcántara-Pilar A, Vilar-Compte D, García-Hubard G, Rojas-Castillo E, Alvarado-Aguilar S, Carrillo JF, Blazeby JM, Aiello-Crocifoglio V. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer. Ann Surg Oncol. 2009;16:88-95. [PMID: 18979141 DOI: 10.1245/s10434-008-0175-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
24 Seo SH, Kang MS, Kim KH, An MS, Ha TK, Bae KB, Oh MK, Choi CS, Oh SH, Choi YK. Correlation of 15-prostagladin dehydrogenase expression with clinicopathological factors and survival rate in gastric adenocarcinoma. Int J Surg 2015;13:96-101. [PMID: 25704623 DOI: 10.1016/j.ijsu.2014.10.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
25 Sun Z, Wang ZN, Zhu Z, Xu YY, Xu Y, Huang BJ, Zhu GL, Xu HM. Evaluation of the seventh edition of American Joint Committee on Cancer TNM staging system for gastric cancer: results from a Chinese monoinstitutional study. Ann Surg Oncol. 2012;19:1918-1927. [PMID: 22246426 DOI: 10.1245/s10434-011-2206-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 6.2] [Reference Citation Analysis]
26 Yang D, Hendifar A, Lenz C, Togawa K, Lenz F, Lurje G, Pohl A, Winder T, Ning Y, Groshen S, Lenz HJ. Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity. J Gastrointest Oncol. 2011;2:77-84. [PMID: 22811834 DOI: 10.3978/j.issn.2078-6891.2010.025] [Cited by in F6Publishing: 72] [Reference Citation Analysis]
27 Zhao S, Shao L, Wang Y, Meng Q, Yu J. Ketamine exhibits anti-gastric cancer activity via induction of apoptosis and attenuation of PI3K/Akt/mTOR. Arch Med Sci 2020;16:1140-9. [PMID: 32864003 DOI: 10.5114/aoms.2019.85146] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Zhu R, Liu F, Grisotti G, Perez-Irizarry J, Salem RR, Cha CH, Johung KL, Boffa DJ, Zhang Y, Khan SA. Clinical impact of underutilization of adjuvant therapy in node positive gastric adenocarcinoma. J Gastrointest Oncol 2018;9:517-26. [PMID: 29998017 DOI: 10.21037/jgo.2018.03.05] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Medina-franco H, Cabrera-mendoza F, Almaguer-rosales S, Guillén F, Suárez-bobadilla YL, Sánchez-ramón A. Lymph Node Ratio as a Predictor of Survival in Gastric Carcinoma. The American Surgeon 2013;79:284-9. [DOI: 10.1177/000313481307900328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Jiang C, Wang Z, Sun Z, Liu F, Yu M, Xu H. Clinicopathologic characteristics and prognosis of gastric cancer invading the subserosa: Gastric Cancer Invading the Subserosa. J Surg Oncol 2010;102:737-41. [DOI: 10.1002/jso.21678] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
31 Chen S, Rao H, Liu J, Geng Q, Guo J, Kong P, Li S, Liu X, Sun X, Zhan Y, Xu D. Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes. Oncotarget 2017;8:45585-96. [PMID: 28489596 DOI: 10.18632/oncotarget.17276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
32 Furuya TK, Jacob CE, Tomitão MTP, Camacho LCC, Ramos MFKP, Eluf-Neto J, Alves VAF, Zilberstein B, Cecconello I, Ribeiro U Jr, Chammas R. Association between Polymorphisms in Inflammatory Response-Related Genes and the Susceptibility, Progression and Prognosis of the Diffuse Histological Subtype of Gastric Cancer. Genes (Basel) 2018;9:E631. [PMID: 30551681 DOI: 10.3390/genes9120631] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
33 Diao L, Li Y, Mei Q, Han W, Hu J. AIB1 induces epithelial-mesenchymal transition in gastric cancer via the PI3K/AKT signaling. J Cell Biochem 2019. [PMID: 31692102 DOI: 10.1002/jcb.29530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Huang Z, Bergholt MS, Zheng W, Lin K, Ho KY, Teh M, Yeoh KG. In vivo early diagnosis of gastric dysplasia using narrow-band image-guided Raman endoscopy. J Biomed Opt 2010;15:037017. [DOI: 10.1117/1.3420115] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
35 Monari M, Trinchero A, Calabrese C, Cattani O, Serrazanetti GP, Foschi J, Fabbri A, Zahlane D, Di Febo G, Tonini V, Cervellera M, Tosi MR, Tugnoli V. Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? Biomarkers 2006;11:574-84. [PMID: 17056476 DOI: 10.1080/13547500600899134] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
36 Eitaki M, Yamamori T, Meike S, Yasui H, Inanami O. Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells. BMC Cancer. 2012;12:469. [PMID: 23057787 DOI: 10.1186/1471-2407-12-469] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
37 Jiao Y, Yang H, Qian J, Gong Y, Liu H, Wu S, Cao L, Tang L. miR‑3664‑5P suppresses the proliferation and metastasis of gastric cancer by attenuating the NF‑κB signaling pathway through targeting MTDH. Int J Oncol 2019;54:845-58. [PMID: 30628643 DOI: 10.3892/ijo.2019.4680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
38 Sugase T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hiramatsu K, Koh M, Saito Y, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Hanazaki K, Mori M, Doki Y, Naka T. Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer. Oncotarget 2018;9:32917-28. [PMID: 30250639 DOI: 10.18632/oncotarget.25952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
39 Sah BK, Zhu ZG, Wang XY, Yang QM, Chen MM, Xiang M, Chen J, Yan M. Post-operative complications of gastric cancer surgery: female gender at high risk. Eur J Cancer Care (Engl) 2009;18:202-8. [PMID: 19267738 DOI: 10.1111/j.1365-2354.2008.01036.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
40 Patel TN, Roy S, Ravi R. Gastric cancer and related epigenetic alterations. Ecancermedicalscience. 2017;11:714. [PMID: 28144288 DOI: 10.3332/ecancer.2017.714] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
41 Kirgiz A, Karaman Erdur S, Kaldirim H, Atalay K, Kocabora MS. Subhyaloid hemorrhage as the first presenting sign of gastric adenocarcinoma. J Fr Ophtalmol 2018;41:e41-2. [PMID: 29310953 DOI: 10.1016/j.jfo.2017.01.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Li G, Xu J, Wang Z, Yuan Y, Li Y, Cai S, He Y. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients. J Cancer Res Clin Oncol 2015;141:443-52. [PMID: 25261987 DOI: 10.1007/s00432-014-1838-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
43 Luo XR, Li JS, Niu Y, Miao L. Targeted killing effects of double CD and TK suicide genes controlled by survivin promoter on gastric cancer cell. Mol Biol Rep. 2011;38:1201-1207. [PMID: 20574710 DOI: 10.1007/s11033-010-0218-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
44 Ghweil AA, Osman HA, Hassan MH, Sabry AM, Mahdy RE, Ahmed AR, Okasha A, Khodeary A, Ameen HH. Validity of serum amyloid A and HMGB1 as biomarkers for early diagnosis of gastric cancer. Cancer Manag Res 2020;12:117-26. [PMID: 32021428 DOI: 10.2147/CMAR.S207934] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
45 Wisnieski F, Geraldis JC, Santos LC, Leal MF, Calcagno DQ, Gigek CO, Chen ES, Anauate AC, Artigiani R, Demachki S, Assumpção PP, Lourenço LG, Arasaki CH, Krainer J, Pabinger S, Burbano RR, Smith MAC. Differential regulation of LRRC37A2 in gastric cancer by DNA methylation. Epigenetics 2021;:1-7. [PMID: 33491552 DOI: 10.1080/15592294.2021.1878724] [Reference Citation Analysis]
46 Fujiya K, Tokunaga M, Mori K, Makuuchi R, Tanizawa Y, Bando E, Kawamura T, Terashima M. Long-Term Survival in Patients with Postoperative Intra-Abdominal Infectious Complications After Curative Gastrectomy for Gastric Cancer: A Propensity Score Matching Analysis. Ann Surg Oncol 2016;23:809-16. [PMID: 27646019 DOI: 10.1245/s10434-016-5577-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
47 McGuckin MA, Every AL, Skene CD, Linden SK, Chionh YT, Swierczak A, McAuley J, Harbour S, Kaparakis M, Ferrero R. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis. Gastroenterology. 2007;133:1210-1218. [PMID: 17919495 DOI: 10.1053/j.gastro.2007.07.003] [Cited by in Crossref: 127] [Cited by in F6Publishing: 125] [Article Influence: 9.1] [Reference Citation Analysis]
48 Dobrițoiu M, Stepan AE, Vere CC, Simionescu CE. Evaluation of Gastric Carcinomas Histological Patterns in Relation to Tumors Aggressiveness Parameters. Curr Health Sci J 2018;44:342-6. [PMID: 31123609 DOI: 10.12865/CHSJ.44.04.03] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Sill M, Schröder C, Shen Y, Marzoq A, Komel R, Hoheisel JD, Nienhüser H, Schmidt T, Kastelic D. Protein Profiling Gastric Cancer and Neighboring Control Tissues Using High-Content Antibody Microarrays. Microarrays (Basel) 2016;5:E19. [PMID: 27600085 DOI: 10.3390/microarrays5030019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
50 Deslandes A. Sonographic demonstration of stomach pathology: Reviewing the cases. Australas J Ultrasound Med 2013;16:202-9. [PMID: 28191199 DOI: 10.1002/j.2205-0140.2013.tb00249.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Kang JH, Kang SH, Seo SH, Shin JH, An MS, Ha TK, Bae KB, Kim TH, Choi CS, Oh SH. Relationship between 15-hydroxyprostaglandin dehydrogenase and gastric adenocarcinoma. Ann Surg Treat Res. 2014;86:302-308. [PMID: 24949321 DOI: 10.4174/astr.2014.86.6.302] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Ji X, Yang Q, Qin H, Zhou J, Liu W. Tumor blood supply may predict neoadjuvant chemotherapy response and survival in patients with gastric cancer. J Int Med Res. 2019;47:2524-2532. [PMID: 31039658 DOI: 10.1177/0300060519845491] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
53 Zhou Z, Lin Z, Pang X, Tariq MA, Ao X, Li P, Wang J. Epigenetic regulation of long non-coding RNAs in gastric cancer. Oncotarget 2018;9:19443-58. [PMID: 29721215 DOI: 10.18632/oncotarget.23821] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
54 Xu DZ, Geng QR, Tian Y, Cai MY, Fang XJ, Zhan YQ, Zhou ZW, Li W, Chen YB, Sun XW. Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer. BMC Cancer. 2010;10:536. [PMID: 20929525 DOI: 10.1186/1471-2407-10-536] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
55 Xie N, Bai Y, Qiao L, Bai Y, Wu J, Li Y, Jiang M, Xu B, Ni Z, Yuan T, Shi Y, Wu K, Xu F, Wang J, Dong L, Liu N. ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments. J Cell Mol Med 2021;25:4014-27. [PMID: 33724652 DOI: 10.1111/jcmm.16366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Laitinen A, Böckelman C, Hagström J, Kokkola A, Fermér C, Nilsson O, Haglund C. Podocalyxin as a Prognostic Marker in Gastric Cancer. PLoS One 2015;10:e0145079. [PMID: 26674770 DOI: 10.1371/journal.pone.0145079] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
57 Díaz de Liaño A, Yarnoz C, Aguilar R, Artieda C, Ortiz H. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer. Gastric Cancer 2008;11:96-102. [PMID: 18595016 DOI: 10.1007/s10120-008-0460-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
58 Liang YX, Guo HH, Deng JY, Wang BG, Ding XW, Wang XN, Zhang L, Liang H. Impact of intraoperative blood loss on survival after curative resection for gastric cancer. World J Gastroenterol 2013; 19(33): 5542-5550 [PMID: 24023499 DOI: 10.3748/wjg.v19.i33.5542] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
59 Haverkamp L, Ruurda JP, Offerhaus GJ, Weijs TJ, van der Sluis PC, van Hillegersberg R. Laparoscopic gastrectomy in Western European patients with advanced gastric cancer. Eur J Surg Oncol 2016;42:110-5. [PMID: 26603678 DOI: 10.1016/j.ejso.2015.09.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
60 Wu XJ, Miao RL, Li ZY, Bu ZD, Zhang LH, Wu AW, Zong XL, Li SX, Shan F, Ji X. Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer. Eur J Surg Oncol. 2015;41:927-933. [PMID: 25913059 DOI: 10.1016/j.ejso.2015.03.225] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
61 Kim DH, Oh CA, Oh SJ, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S. Validation of seventh edition AJCC gastric cancer staging modifications. J Surg Oncol. 2012;105:26-30. [PMID: 21761411 DOI: 10.1002/jso.22026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
62 Sun Z, Zhu GL, Lu C, Guo PT, Huang BJ, Li K, Xu Y, Li DM, Wang ZN, Xu HM. The impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patients. Ann Oncol. 2009;20:897-905. [PMID: 19179553 DOI: 10.1093/annonc/mdn707] [Cited by in Crossref: 71] [Cited by in F6Publishing: 87] [Article Influence: 5.9] [Reference Citation Analysis]
63 Ruíz-García E, Guadarrama-Orozco J, Vidal-Millán S, Lino-Silva LS, López-Camarillo C, Astudillo-de la Vega H. Gastric cancer in Latin America. Scand J Gastroenterol 2018;53:124-9. [PMID: 29275643 DOI: 10.1080/00365521.2017.1417473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
64 Bordeira-Carriço R, Ferreira D, Mateus DD, Pinheiro H, Pêgo AP, Santos MA, Oliveira C. Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA. Eur J Hum Genet 2014;22:1085-92. [PMID: 24424122 DOI: 10.1038/ejhg.2013.292] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
65 Boroumand-Noughabi S, Sima HR, Ghaffarzadehgan K, Jafarzadeh M, Raziee HR, Hosseinnezhad H, Moaven O, Rajabi-Mashhadi MT, Azarian AA, Mashhadinejad M, Tavakkol-Afshari J. Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma. BMC Cancer 2010;10:275. [PMID: 20534173 DOI: 10.1186/1471-2407-10-275] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
66 Nicoud MB, Formoso K, Medina VA. Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications. Front Pharmacol 2019;10:556. [PMID: 31231212 DOI: 10.3389/fphar.2019.00556] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
67 Sheibani S, Mahmoudian RA, Abbaszadegan MR, Chamani J, Memar B, Gholamin M. Expression analysis of matrix metalloproteinase-13 in human gastric cancer in the presence of Helicobacter Pylori infection. Cancer Biomark 2017;18:349-56. [PMID: 28128735 DOI: 10.3233/CBM-160127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Niu W, Pang Q, Lin T, Wang Z, Zhang J, Tai M, Zhang L, Zhang L, Gu M, Liu C, Qu K. A Causal Role of Genetically Elevated Circulating Interleukin-10 in the Development of Digestive Cancers: Evidence from Mendelian Randomization Analysis Based on 29,307 Subjects. Medicine (Baltimore) 2016;95:e2799. [PMID: 26886630 DOI: 10.1097/MD.0000000000002799] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
69 Song KY, Jung CK, Park WS, Park CH. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma. Jpn J Clin Oncol. 2009;39:290-296. [PMID: 19336448 DOI: 10.1093/jjco/hyp020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
70 Takeno A, Takemasa I, Doki Y, Yamasaki M, Miyata H, Takiguchi S, Fujiwara Y, Matsubara K, Monden M. Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis. Br J Cancer 2008;99:1307-15. [PMID: 18827816 DOI: 10.1038/sj.bjc.6604682] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
71 Marchet A, Mocellin S, Belluco C, Ambrosi A, DeMarchi F, Mammano E, Digito M, Leon A, D'Arrigo A, Lise M, Nitti D. Gene expression profile of primary gastric cancer: towards the prediction of lymph node status. Ann Surg Oncol. 2007;14:1058-1064. [PMID: 17106627 DOI: 10.1245/s10434-006-9090-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
72 Chen S, Ou-Yang LY, Nie RC, Li YF, Xiang J, Zhou ZW, Chen YB, Peng JS. Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T3-4aN0M0 Gastric Cancer Patients after D2 Gastrectomy. Gastroenterol Res Pract 2017;2017:4928736. [PMID: 28331491 DOI: 10.1155/2017/4928736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
73 Zhou WH, Tang F, Xu J, Wu X, Feng ZY, Li HG, Lin DJ, Shao CK, Liu Q. Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer. BMC Cancer 2011;11:397. [PMID: 21933426 DOI: 10.1186/1471-2407-11-397] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
74 Cui D, Zhang C, Liu B, Shu Y, Du T, Shu D, Wang K, Dai F, Liu Y, Li C, Pan F, Yang Y, Ni J, Li H, Brand-Saberi B, Guo P. Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA. Sci Rep 2015;5:10726. [PMID: 26137913 DOI: 10.1038/srep10726] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 10.0] [Reference Citation Analysis]
75 Lin S, Ma R, Zheng XY, Yu H, Liang X, Lin H, Cai XJ. Meta-analysis of immunohistochemical expression of hypoxia inducible factor-1α as a prognostic role in gastric cancer. World J Gastroenterol 2014; 20(4): 1107-1113 [PMID: 24574785 DOI: 10.3748/wjg.v20.i4.1107] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
76 Kim JW, Shin SS, Heo SH, Lim HS, Lim NY, Park YK, Jeong YY, Kang HK. The role of three-dimensional multidetector CT gastrography in the preoperative imaging of stomach cancer: emphasis on detection and localization of the tumor. Korean J Radiol. 2015;16:80-89. [PMID: 25598676 DOI: 10.3348/kjr.2015.16.1.80] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
77 de Sá JS, Moreira DC, Louvera Silva KA, Morgano MA, Quintaes KD. Consumption of oral hospital diets and percent adequacy of minerals in oncology patients as an indicative for the use of oral supplements. Clinical Nutrition 2014;33:655-61. [DOI: 10.1016/j.clnu.2013.09.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
78 Garland SN, Pelletier G, Lawe A, Biagioni BJ, Easaw J, Eliasziw M, Cella D, Bathe OF. Prospective evaluation of the reliability, validity, and minimally important difference of the functional assessment of cancer therapy-gastric (FACT-Ga) quality-of-life instrument. Cancer 2011;117:1302-12. [DOI: 10.1002/cncr.25556] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
79 Lorenzon L, Cippitelli C, Avantifiori R, Uccini S, French D, Torrisi MR, Ranieri D, Mercantini P, Canu V, Blandino G, Cavallini M. Down-regulated miRs specifically correlate with non-cardial gastric cancers and Lauren's classification system. J Surg Oncol 2017;116:184-94. [PMID: 28475823 DOI: 10.1002/jso.24648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
80 Liu Z, Feng F, Guo M, Liu S, Zheng G, Xu G, Lian X, Fan D, Zhang H. Distal gastrectomy versus total gastrectomy for distal gastric cancer. Medicine (Baltimore). 2017;96:e6003. [PMID: 28151896 DOI: 10.1097/md.0000000000006003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
81 Liang Y, Ding X, Wang X, Wang B, Deng J, Zhang L, Liang H. Prognostic value of surgical margin status in gastric cancer patients. ANZ J Surg 2015;85:678-84. [PMID: 24438078 DOI: 10.1111/ans.12515] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
82 Xiao L, Li M, Xu F, Ye H, Wu W, Long S, Li W, He Y. Extended multi-organ resection for cT4 gastric carcinoma: A retrospective analysis. Pak J Med Sci 2013;29:581-5. [PMID: 24353581 DOI: 10.12669/pjms.292.2898] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
83 Guo T, Yu Y, Yip GW, Baeg GH, Thike AA, Lim TK, Tan PH, Matsumoto K, Bay BH. Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer. Histopathology. 2015;66:491-499. [PMID: 25270600 DOI: 10.1111/his.12570] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
84 Liu Y, Chen X, Chen X, Yang X, Song Q, Wu H. High SALM3 Expression in Tumor Cells and Fibroblasts Is Correlated with Poor Prognosis in Gastric Cancer Patients. Dis Markers 2019;2019:8282414. [PMID: 31089399 DOI: 10.1155/2019/8282414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Sohn SH, Sul HJ, Kim B, Kim BJ, Kim HS, Zang DY. Tepotinib Inhibits the Epithelial-Mesenchymal Transition and Tumor Growth of Gastric Cancers by Increasing GSK3β, E-Cadherin, and Mucin 5AC and 6 Levels. Int J Mol Sci 2020;21:E6027. [PMID: 32825724 DOI: 10.3390/ijms21176027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Tsai JH, Jeng YM, Chen KH, Lee CH, Yuan CT, Liau JY. An Integrative Morphomolecular Classification System of Gastric Carcinoma With Distinct Clinical Outcomes. Am J Surg Pathol 2020;44:1017-30. [PMID: 32568823 DOI: 10.1097/PAS.0000000000001521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
87 Xu C, Wang J, Li J, Fang R. Expression of elongation factor (EF)-Tu is correlated with prognosis of gastric adenocarcinomas. Int J Mol Sci 2011;12:6645-55. [PMID: 22072909 DOI: 10.3390/ijms12106645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
88 Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol 2014; 20(38): 13804-13819 [PMID: 25320518 DOI: 10.3748/wjg.v20.i38.13804] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
89 Kim SY, Hwang YS, Sohn TS, Oh SJ, Choi MG, Noh JH, Bae JM, Kim S. The predictors and clinical impact of positive resection margins on frozen section in gastric cancer surgery. J Gastric Cancer 2012;12:113-9. [PMID: 22792524 DOI: 10.5230/jgc.2012.12.2.113] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
90 Choong ML, Tan SH, Tan TZ, Manesh S, Ngo A, Yong JW, Yang HH, Lee MA. Molecular integrative clustering of Asian gastric cell lines revealed two distinct chemosensitivity clusters. PLoS One 2014;9:e111146. [PMID: 25343454 DOI: 10.1371/journal.pone.0111146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
91 Khanna A, Böckelman C, Hemmes A, Junttila MR, Wiksten JP, Lundin M, Junnila S, Murphy DJ, Evan GI, Haglund C, Westermarck J, Ristimäki A. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. J Natl Cancer Inst 2009;101:793-805. [PMID: 19470954 DOI: 10.1093/jnci/djp103] [Cited by in Crossref: 137] [Cited by in F6Publishing: 126] [Article Influence: 11.4] [Reference Citation Analysis]
92 Cascinu S, Labianca R, Barone C, Santoro A, Carnaghi C, Cassano A, Beretta GD, Catalano V, Bertetto O, Barni S, Frontini L, Aitini E, Rota S, Torri V, Floriani I, Pozzo C, Rimassa L, Mosconi S, Giordani P, Ardizzoia A, Foa P, Rabbi C, Chiara S, Gasparini G, Nardi M, Mansutti M, Arnoldi E, Piazza E, Cortesi E, Pucci F, Silva RR, Sobrero A, Ravaioli A; Italian Group for the Study of Digestive Tract Cancer. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. J Natl Cancer Inst 2007;99:601-7. [PMID: 17440161 DOI: 10.1093/jnci/djk131] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 5.3] [Reference Citation Analysis]
93 Zhang J, Zou S, Luo R, Zhu Z, Xu H, Huang B. Proposal of a novel stage grouping of the Eighth Edition of American Joint Committee on Cancer TNM Staging System for Gastric Cancer: results from a retrospective study of 30 years clinical data from a single institute in China. Expert Rev Gastroenterol Hepatol 2020;14:55-64. [PMID: 31062631 DOI: 10.1080/17474124.2019.1613152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
94 Huang CM, Xu M, Wang JB, Zheng CH, Li P, Xie JW, Lin JX, Lu J. Is tumor size a predictor of preoperative N staging in T2-T4a stage advanced gastric cancer? Surg Oncol. 2014;23:5-10. [PMID: 24508061 DOI: 10.1016/j.suronc.2014.01.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
95 Hong C, Yang S, Wang Q, Zhang S, Wu W, Chen J, Zhong D, Li M, Li L, Li J, Yu H, Chen H, Zeng Q, Zhang C. Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis. Front Genet 2021;12:563051. [PMID: 33815458 DOI: 10.3389/fgene.2021.563051] [Reference Citation Analysis]
96 Oñate-Ocaña LF, Becker M, Carrillo JF, Aiello-Crocifoglio V, Gallardo-Rincón D, Brom-Valladares R, Herrera-Goepfert R, Ochoa-Carrillo F, Beltrán-Ortega A. Selection of best candidates for multiorgan resection among patients with T4 gastric carcinoma. J Surg Oncol 2008;98:336-42. [PMID: 18646043 DOI: 10.1002/jso.21118] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
97 Owen GI, Pinto MP, Retamal IN, Fernádez MF, Cisternas B, Mondaca S, Sanchez C, Galindo H, Nervi B, Ibañez C, Acevedo F, Madrid J, Peña J, Bravo ML, Maturana MJ, Cordova-Delgado M, Romero D, de la Jara N, Torres J, Rodriguez-Fernandez M, Espinoza M, Balmaceda C, Freire M, Gárate-Calderón V, Crovari F, Jimenez-Fonseca P, Carmona-Bayonas A, Zwenger A, Armisen R, Corvalan AH, Garrido M. Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients. Medicine (Baltimore) 2018;97:e0419. [PMID: 29668600 DOI: 10.1097/MD.0000000000010419] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
98 Jiang B, Zhu K, Shao H, Bao C, Ou J, Sun W. Lack of association between the CDH1 polymorphism and gastric cancer susceptibility: a meta-analysis. Sci Rep 2015;5:7891. [PMID: 25599647 DOI: 10.1038/srep07891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
99 Marchet A, Mocellin S, Ambrosi A, Morgagni P, Vittimberga G, Roviello F, Marrelli D, de Manzoni G, Minicozzi A, Coniglio A. Validation of the new AJCC TNM staging system for gastric cancer in a large cohort of patients (n = 2155): focus on the T category. Eur J Surg Oncol. 2011;37:779-785. [PMID: 21726975 DOI: 10.1016/j.ejso.2011.06.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
100 Fernandez-Botran R, Wellmann IA, Une C, Méndez-Chacón E, Hernández de Rodas E, Bhandari B, Villagrán de Tercero CI. Seroprevalence of Helicobacter pylori/CagA Antibodies in Guatemalan Gastric Cancer Patients: Association of Seropositivity with Increased Plasma Levels of Pepsinogens but not Soluble Urokinase Plasminogen Activator Receptor. Am J Trop Med Hyg 2020;103:260-5. [PMID: 32314688 DOI: 10.4269/ajtmh.19-0934] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Zhou YX, Yang LP, Wang ZX, He MM, Yun JP, Zhang DS, Wang F, Xu RH. Lymph node staging systems in patients with gastric cancer treated with D2 resection plus adjuvant chemotherapy. J Cancer 2018;9:660-6. [PMID: 29556323 DOI: 10.7150/jca.22016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
102 Zakaria A, Khan F, Ahmad S, Turk I, Levinson J. Massive gastric distension due to signet-ring cell gastric adenocarcinoma. J Family Med Prim Care 2020;9:2558-61. [PMID: 32754546 DOI: 10.4103/jfmpc.jfmpc_170_20] [Reference Citation Analysis]
103 Teh SK, Zheng W, Ho KY, Teh M, Yeoh KG, Huang Z. Near-infrared Raman spectroscopy for early diagnosis and typing of adenocarcinoma in the stomach. British Journal of Surgery 2010;97:550-7. [DOI: 10.1002/bjs.6913] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
104 Al-Abdulla R, Perez-Silva L, Lozano E, Macias RIR, Herraez E, Abad M, Segues N, Bujanda L, Briz O, Marin JJG. Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters. Biochem Pharmacol 2020;171:113682. [PMID: 31669256 DOI: 10.1016/j.bcp.2019.113682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 El Hanafy E, El Nakeeb A, Ezzat H, Hamdy E, Atif E, Kandil T, Fouad A, Wahab MA, Monier A. How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience. World J Gastrointest Surg 2016; 8(6): 444-451 [PMID: 27358677 DOI: 10.4240/wjgs.v8.i6.444] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Xu ZY, Chen JS, Shu YQ. Gene expression profile towards the prediction of patient survival of gastric cancer. Biomed Pharmacother 2010;64:133-9. [PMID: 20005068 DOI: 10.1016/j.biopha.2009.06.021] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
107 Díaz de Liaño A, Yárnoz C, Aguilar R, Artieda C, Ortiz H. [Morbidity and mortality in gastrectomy with D2 lymphadenectomy in a specialised unit]. Cir Esp 2008;83:18-23. [PMID: 18208744 DOI: 10.1016/s0009-739x(08)70491-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
108 Riquelme I, Tapia O, Leal P, Sandoval A, Varga MG, Letelier P, Buchegger K, Bizama C, Espinoza JA, Peek RM. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway. Cell Oncol (Dordr). 2016;39:23-33. [PMID: 26458815 DOI: 10.1007/s13402-015-0247-3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 11.0] [Reference Citation Analysis]
109 Moslim MA, Heald B, Tu C, Burke CA, Walsh RM. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer. Surgery. 2018;164:754-759. [PMID: 30145018 DOI: 10.1016/j.surg.2018.05.059] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
110 Hang Q, Sun R, Jiang C, Li Y. Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression. Anticancer Drugs. 2015;26:632-640. [PMID: 25763542 DOI: 10.1097/cad.0000000000000227] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
111 Martella L, Bertozzi S, Londero AP, Steffan A, De Paoli P, Bertola G. Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies. Medicine (Baltimore). 2015;94:e1113. [PMID: 26252272 DOI: 10.1097/md.0000000000001113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
112 Ribeiro CH, Kramm K, Gálvez-Jirón F, Pola V, Bustamante M, Contreras HR, Sabag A, Garrido-Tapia M, Hernández CJ, Zúñiga R, Collazo N, Sotelo PH, Morales C, Mercado L, Catalán D, Aguillón JC, Molina MC. Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients. Oncol Rep 2016;35:1309-17. [PMID: 26708143 DOI: 10.3892/or.2015.4510] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
113 Kanda M, Shimizu D, Tanaka H, Tanaka C, Kobayashi D, Hayashi M, Iwata N, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer. Ann Surg. 2018;267:495-503. [PMID: 28026832 DOI: 10.1097/sla.0000000000002096] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 21.5] [Reference Citation Analysis]
114 Díaz de Liaño A, Yárnoz C, Artieda C, Aguilar R, Viana S, Artajona A, Ortiz H. Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer. Clin Transl Oncol 2009;11:178-82. [PMID: 19293056 DOI: 10.1007/s12094-009-0335-9] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
115 Kang YK, Rha SY, Tassone P, Barriuso J, Yu R, Szado T, Garg A, Bang YJ. A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer. Br J Cancer. 2014;111:660-666. [PMID: 24960402 DOI: 10.1038/bjc.2014.356] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
116 Wang P, Xiao F, Gong B, Liu F, Xu H. A Nomogram for Predicting Overall Survival of Gastric Cancer Patients with Insufficient Lymph Nodes Examined. J Gastrointest Surg 2017;21:947-56. [DOI: 10.1007/s11605-017-3401-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
117 Baron H, Šlapeta J, Donahoe S, Doneley R, Phalen D. Compensatory gastric stretching following subtotal gastric resection due to gastric adenocarcinoma in a diamond python ( Morelia spilota spilota ). Aust Vet J 2018;96:481-6. [DOI: 10.1111/avj.12764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 Nitti D, Marchet A, Mocellin S, Rossi GM, Ambrosi A, Mencarelli R. Prognostic value of subclassification of T2 tumours in patients with gastric cancer. Br J Surg. 2009;96:398-404. [PMID: 19283740 DOI: 10.1002/bjs.6487] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
119 Park SK, Park YS, Ahn JY, Do EJ, Kim D, Kim JE, Jung K, Byeon JS, Ye BD, Yang DH. MiR 21-5p as a predictor of recurrence in young gastric cancer patients. J Gastroenterol Hepatol. 2016;31:1429-1435. [PMID: 26824898 DOI: 10.1111/jgh.13300] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
120 Lin GT, Chen QY, Zhong Q, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Huang CM. Intraoperative Surrogate Indicators of Gastric Cancer Patients' Long-Term Prognosis: The Number of Lymph Nodes Examined Relates to the Lymph Node Noncompliance Rate. Ann Surg Oncol 2020;27:3281-93. [PMID: 32212034 DOI: 10.1245/s10434-020-08387-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
121 Zhu GL, Sun Z, Wang ZN, Xu YY, Huang BJ, Xu Y, Zhu Z, Xu HM. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach. J Surg Oncol. 2012;105:786-792. [PMID: 22105768 DOI: 10.1002/jso.22149] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
122 Deng J, Liang H, Wang D, Sun D, Ding X, Pan Y, Liu X. Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes. Ann Surg Oncol. 2010;17:1043-1051. [PMID: 20039218 DOI: 10.1245/s10434-009-0863-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 56] [Article Influence: 4.0] [Reference Citation Analysis]
123 Yunker JJ, Vicinanzo MG, Braswell RA, Read RW, Goldin GF, Long JA. Unusual Presentation of Gastric Adenocarcinoma Metastatic to the Orbit. Ophthalmic Plastic & Reconstructive Surgery 2006;22:490-1. [DOI: 10.1097/01.iop.0000245484.65470.51] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
124 Oliveira C, Seruca R, Carneiro F. Hereditary gastric cancer. Best Practice & Research Clinical Gastroenterology 2009;23:147-57. [DOI: 10.1016/j.bpg.2009.02.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
125 Wang YN, Shen KT, Ling JQ, Gao XD, Hou YY, Wang XF, Qin J, Sun YH, Qin XY. Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases. BMC Surg. 2012;12:20. [PMID: 23062030 DOI: 10.1186/1471-2482-12-20] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
126 Huang XY, Liu JJ, Liu X, Wang YH, Xiang W. Bioinformatics analysis of the prognosis and biological significance of VCAN in gastric cancer. Immun Inflamm Dis 2021;9:547-59. [PMID: 33631054 DOI: 10.1002/iid3.414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
127 Korenberg MJ, Dicken BJ, Damaraju S, Graham K, Cass CE. Predicting node positivity in gastric cancer from gene expression profiles. Biotechnol Lett 2009;31:1381-8. [DOI: 10.1007/s10529-009-0035-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
128 Nakamoto Y, Togashi K, Kaneta T, Fukuda H, Nakajima K, Kitajima K, Murakami K, Fujii H, Satake M, Tateishi U. Clinical value of whole-body FDG-PET for recurrent gastric cancer: a multicenter study. Jpn J Clin Oncol. 2009;39:297-302. [PMID: 19269991 DOI: 10.1093/jjco/hyp010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
129 Park SR, Kim MJ, Ryu KW, Lee JH, Lee JS, Nam BH, Choi IJ, Kim YW. Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: a viewpoint in the era of preoperative treatment. Ann Surg. 2010;251:428-435. [PMID: 20179530 DOI: 10.1097/sla.0b013e3181ca69a7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
130 Mocellin S, Marchet A, Nitti D. EUS for the staging of gastric cancer: a meta-analysis. Gastrointest Endosc. 2011;73:1122-1134. [PMID: 21444080 DOI: 10.1016/j.gie.2011.01.030] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 7.4] [Reference Citation Analysis]
131 Lee JH, Kim YI. Which Is the Optimal Extent of Resection in Middle Third Gastric Cancer between Total Gastrectomy and Subtotal Gastrectomy? J Gastric Cancer. 2010;10:226-233. [PMID: 22076190 DOI: 10.5230/jgc.2010.10.4.226] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
132 Hosoda K, Yamashita K, Katada N, Moriya H, Mieno H, Sakuramoto S, Kikuchi S, Watanabe M. Preoperative tumor size is a critical prognostic factor for patients with Borrmann type III gastric cancer. Surg Today. 2015;45:68-77. [PMID: 25352012 DOI: 10.1007/s00595-014-1060-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
133 Graziosi L, Mencarelli A, Santorelli C, Renga B, Cipriani S, Cavazzoni E, Palladino G, Laufer S, Burnet M, Donini A. Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis. Eur J Pharmacol. 2012;674:143-152. [PMID: 22119383 DOI: 10.1016/j.ejphar.2011.11.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
134 Keese M, Gasimova L, Schwenke K, Yagublu V, Shang E, Faissner R, Lewis A, Samel S, Löhr M. Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer. Int J Cancer. 2009;124:2701-2708. [PMID: 19165866 DOI: 10.1002/ijc.24211] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
135 Dias Rodrigues V, Barroso de Pinho N, Abdelhay E, Viola JP, Correia MI, Brum Martucci R. Nutrition and Immune-Modulatory Intervention in Surgical Patients With Gastric Cancer. Nutr Clin Pract. 2017;32:122-129. [PMID: 27329862 DOI: 10.1177/0884533616653807] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
136 de la Peña S, L. Sampieri C, León-córdoba K. Metaloproteasas de la matriz extracelular como marcadores moleculares en cáncer gástrico. Medicina Clínica 2010;134:123-6. [DOI: 10.1016/j.medcli.2009.09.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
137 Calcagno DQ, Freitas VM, Leal MF, de Souza CR, Demachki S, Montenegro R, Assumpção PP, Khayat AS, Smith Mde A, dos Santos AK, Burbano RR. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer. BMC Gastroenterol 2013;13:141. [PMID: 24053468 DOI: 10.1186/1471-230X-13-141] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 7.8] [Reference Citation Analysis]
138 Wang RG, Zhang D, Zhao CH, Wang QL, Qu H, He QS. FKBP10 functioned as a cancer-promoting factor mediates cell proliferation, invasion, and migration via regulating PI3K signaling pathway in stomach adenocarcinoma. Kaohsiung J Med Sci 2020;36:311-7. [PMID: 31868996 DOI: 10.1002/kjm2.12174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
139 Cao LL, Lu J, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Lin M, Tu RH, Zheng CH, Huang CM. Evaluation of the Eighth Edition of the American Joint Committee on Cancer TNM Staging System for Gastric Cancer: An Analysis of 7371 Patients in the SEER Database. Gastroenterol Res Pract 2019;2019:6294382. [PMID: 31097961 DOI: 10.1155/2019/6294382] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
140 Russi S, Verma HK, Laurino S, Mazzone P, Storto G, Nardelli A, Zoppoli P, Calice G, La Rocca F, Sgambato A, Lucci V, Falco G, Ruggieri V. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells. Int J Mol Sci 2019;20:E3736. [PMID: 31370155 DOI: 10.3390/ijms20153736] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
141 Dong L, Li J, Lou XP, Miao JH, Lu P, Chang ZW, Han ZF. Comparison of short-term efficacy and safety of TIROX and DCF regimens for advanced gastric cancer. J Int Med Res. 2014;42:737-743. [PMID: 24717407 DOI: 10.1177/0300060513510657] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
142 Zheng Y, Jia Y, Wang Y, Wang M, Li B, Shi X, Ma X, Xiao D, Sun Y. The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in gastric cancer. OMICS 2009;13:301-6. [PMID: 19624270 DOI: 10.1089/omi.2009.0014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
143 Bal N, Yildirim S, Nursal TZ, Bolat F, Kayaselçuk F. Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type. World J Gastroenterol 2007; 13(27): 3726-3729 [PMID: 17659733 DOI: 10.3748/wjg.v13.i27.3726] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
144 Cheng W, Wang C, Huang Y, Liang Y, Lin PY, Hsueh C, Wu Y, Chen W, Yu C, Lin S, Lin K. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer 2008;123:1787-96. [DOI: 10.1002/ijc.23746] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
145 Ang YL, Yong WP, Tan P. Translating gastric cancer genomics into targeted therapies. Crit Rev Oncol Hematol. 2016;100:141-146. [PMID: 26947813 DOI: 10.1016/j.critrevonc.2016.02.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
146 Tüzün S, Yücel AF, Pergel A, Kemik AS, Kemik O. Lipid Peroxidation and Transforming Growth Factor-β1 Levels in Gastric Cancer at Pathologic Stages. Balkan Med J 2012;29:273-6. [PMID: 25207013 DOI: 10.5152/balkanmedj.2012.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
147 Yi JH, Jang J, Cho J, Do IG, Hong M, Kim ST, Kim KM, Lee S, Park SH, Park JO, Park YS, Kang WK, Lim HY, Lee J. MerTK is a novel therapeutic target in gastric cancer. Oncotarget 2017;8:96656-67. [PMID: 29228560 DOI: 10.18632/oncotarget.3750] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
148 Kim KC, Yook JH, Eisenbraun J, Kim BS, Huber R. Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study. BMC Complement Altern Med 2012;12:172. [PMID: 23033982 DOI: 10.1186/1472-6882-12-172] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
149 Kolev Y, Uetake H, Takagi Y, Sugihara K. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol. 2008;15:2336-2344. [PMID: 18521687 DOI: 10.1245/s10434-008-9955-5] [Cited by in Crossref: 125] [Cited by in F6Publishing: 117] [Article Influence: 9.6] [Reference Citation Analysis]
150 Koopman T, Louwen M, Hage M, Smits MM, Imholz AL. Pathologic Diagnostics of HER2 Positivity in Gastroesophageal Adenocarcinoma. American Journal of Clinical Pathology 2015;143:257-64. [DOI: 10.1309/ajcpcx69hgddgycq] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
151 Bouliaris K, Rachiotis G, Diamantis A, Christodoulidis G, Polychronopoulou E, Tepetes K. Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system. European Journal of Surgical Oncology (EJSO) 2017;43:1350-6. [DOI: 10.1016/j.ejso.2017.03.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
152 Wang T, Fei HJ, Yang Y, Jiang XS, Yan M, Zeng Z, Wu J, Song LJ, Tian H, Fu GH. Expression of AE1/p16 promoted degradation of AE2 in gastric cancer cells. BMC Cancer 2016;16:716. [PMID: 27595783 DOI: 10.1186/s12885-016-2751-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
153 Tee MC, Pirozzi N, Brahmbhatt RD, Raman S, Franko J. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States. Eur J Surg Oncol 2020;46:1941-7. [PMID: 32466860 DOI: 10.1016/j.ejso.2020.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
154 Li H, Piao L, Xu D, Xuan Y. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma. Experimental and Molecular Pathology 2020;112:104333. [DOI: 10.1016/j.yexmp.2019.104333] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
155 Haverkamp L, Weijs TJ, van der Sluis PC, van der Tweel I, Ruurda JP, van Hillegersberg R. Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis. Surg Endosc. 2013;27:1509-1520. [PMID: 23263644 DOI: 10.1007/s00464-012-2661-1] [Cited by in Crossref: 121] [Cited by in F6Publishing: 102] [Article Influence: 13.4] [Reference Citation Analysis]
156 Lemke J, Scheele J, Kapapa T, von Karstedt S, Wirtz CR, Henne-Bruns D, Kornmann M. Brain metastases in gastrointestinal cancers: is there a role for surgery? Int J Mol Sci 2014;15:16816-30. [PMID: 25247579 DOI: 10.3390/ijms150916816] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
157 Janke L, Carlson CS, St. Hill CA. The Novel Carbohydrate Tumor Antigen C2-O-sLe x Is Upregulated in Canine Gastric Carcinomas. Vet Pathol 2010;47:455-61. [DOI: 10.1177/0300985810363700] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
158 Kim S, Ki CS, Kim KM, Lee MG, Kim S, Bae JM, Kim JW. Novel mechanism of a CDH1 splicing mutation in a Korean patient with signet ring cell carcinoma. BMB Rep 2011;44:725-9. [PMID: 22118538 DOI: 10.5483/bmbrep.2011.44.11.725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
159 Nisimova L, Wen S, Cross-Knorr S, Rogers AB, Moss SF, Chatterjee D. Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer. Crit Rev Oncog 2014;19:469-81. [PMID: 25597356 DOI: 10.1615/critrevoncog.2014012044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
160 Quadri HS, Smaglo BG, Morales SJ, Phillips AC, Martin AD, Chalhoub WM, Haddad NG, Unger KR, Levy AD, Al-Refaie WB. Gastric Adenocarcinoma: A Multimodal Approach.Front Surg. 2017;4:42. [PMID: 28824918 DOI: 10.3389/fsurg.2017.00042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
161 Lee JW, Ali B, Park CH, Song KY. Different lymph node staging systems in patients with gastric cancer from Korean: What is the best prognostic assessment tool? Medicine (Baltimore) 2016;95:e3860. [PMID: 27336871 DOI: 10.1097/MD.0000000000003860] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
162 Sayer JR, Walldén K, Koss H, Allan H, Daviter T, Gane PJ, Waksman G, Tabor AB. Design, synthesis, and evaluation of peptide-imidazo[1,2-a]pyrazine bioconjugates as potential bivalent inhibitors of the VirB11 ATPase HP0525. J Pept Sci 2021;:e3353. [PMID: 34142414 DOI: 10.1002/psc.3353] [Reference Citation Analysis]
163 Lee CM, Jee YS, Lee JH, Son SY, Ahn SH, Park DJ, Kim HH. Length of negative resection margin does not affect local recurrence and survival in the patients with gastric cancer. World J Gastroenterol 2014; 20(30): 10518-10524 [PMID: 25132770 DOI: 10.3748/wjg.v20.i30.10518] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
164 Yuan W, Chen Z, Wu S, Ge J, Chang S, Wang X, Chen J, Chen Z. Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis. Pathol Oncol Res. 2009;15:473-478. [PMID: 19048396 DOI: 10.1007/s12253-008-9132-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
165 Lei Z, Tan IB, Das K, Deng N, Zouridis H, Pattison S, Chua C, Feng Z, Guan YK, Ooi CH, Ivanova T, Zhang S, Lee M, Wu J, Ngo A, Manesh S, Tan E, Teh BT, So JB, Goh LK, Boussioutas A, Lim TK, Flotow H, Tan P, Rozen SG. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology. 2013;145:554-565. [PMID: 23684942 DOI: 10.1053/j.gastro.2013.05.010] [Cited by in Crossref: 242] [Cited by in F6Publishing: 228] [Article Influence: 30.3] [Reference Citation Analysis]
166 Grasso M, Pacella G, Sangiuliano N, De Palma M, Puzziello A. Gastric cancer surgery: clinical outcomes and prognosis are influenced by perioperative blood transfusions. Updates Surg 2019;71:439-43. [PMID: 30659478 DOI: 10.1007/s13304-019-00622-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
167 Oñate-Ocaña LF, Méndez-Cruz G, Hernández-Ramos R, Becker M, Carrillo JF, Herrera-Goepfert R, Aiello-Crocifoglio V, Ochoa-Carrillo F, Beltrán-Ortega A. Experience of surgical morbidity after palliative surgery in patients with gastric carcinoma. Gastric Cancer 2007;10:215-20. [PMID: 18095076 DOI: 10.1007/s10120-007-0437-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
168 Lai H, Jin Q, Lin Y, Mo X, Li B, He K, Chen J. Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer. Tumour Biol 2014;35:10547-54. [PMID: 25060181 DOI: 10.1007/s13277-014-2355-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
169 Feichtinger RG, Neureiter D, Skaria T, Wessler S, Cover TL, Mayr JA, Zimmermann FA, Posselt G, Sperl W, Kofler B. Oxidative Phosphorylation System in Gastric Carcinomas and Gastritis. Oxid Med Cell Longev 2017;2017:1320241. [PMID: 28744336 DOI: 10.1155/2017/1320241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
170 Cho SJ, Yoon C, Lee JH, Chang KK, Lin JX, Kim YH, Kook MC, Aksoy BA, Park DJ, Ashktorab H, Smoot DT, Schultz N, Yoon SS. KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Promote Epithelial-to-Mesenchymal Transition. Clin Cancer Res 2018;24:6556-69. [PMID: 30108106 DOI: 10.1158/1078-0432.CCR-17-1679] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
171 Yu HF, Zhao G, Ge ZJ, Wang DR, Chen J, Zhang Y, Zha TZ, Zhang K, Zhang M, Tan YF, Zhou SJ, Jiang C. High RIN1 expression is associated with poor prognosis in patients with gastric adenocarcinoma. Tumour Biol 2012;33:1557-63. [PMID: 22562267 DOI: 10.1007/s13277-012-0409-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
172 Qiu FM, Yu JK, Chen YD, Jin QF, Sui MH, Huang J. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics. J Exp Clin Cancer Res 2009;28:126. [PMID: 19740432 DOI: 10.1186/1756-9966-28-126] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
173 Scartozzi M, Loretelli C, Galizia E, Mandolesi A, Pistelli M, Bittoni A, Giampieri R, Faloppi L, Bianconi M, Del Prete M, Bianchi F, Belvederesi L, Bearzi I, Cascinu S. Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. PLoS One 2012;7:e38192. [PMID: 22808003 DOI: 10.1371/journal.pone.0038192] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
174 Mao ZY, Guo XC, Su D, Wang LJ, Zhang TT, Bai L. Retrospective evaluation of the efficacy of first-line treatment of advanced gastric cancer with docetaxel and oxaliplatin. Cancer Invest 2015;33:16-21. [PMID: 25495414 DOI: 10.3109/07357907.2014.988342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
175 Tiberio GA, Coniglio A, Marchet A, Marrelli D, Giacopuzzi S, Baiocchi L, Roviello F, de Manzoni G, Nitti D, Giulini SM. Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. Eur J Surg Oncol. 2009;35:486-491. [PMID: 19171450 DOI: 10.1016/j.ejso.2008.12.017] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
176 Ishiwatari T, Okubo Y, Tochigi N, Wakayama M, Nemoto T, Kobayashi J, Shinozaki M, Aki K, Sasai D, Yamamoto Y. Remodeling of the pulmonary artery induced by metastatic gastric carcinoma: a histopathological analysis of 51 autopsy cases. BMC Cancer. 2014;14:14. [PMID: 24410891 DOI: 10.1186/1471-2407-14-14] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
177 Lai AZ, Cory S, Zhao H, Gigoux M, Monast A, Guiot MC, Huang S, Tofigh A, Thompson C, Naujokas M, Marcus VA, Bertos N, Sehat B, Perera RM, Bell ES, Page BD, Gunning PT, Ferri LE, Hallett M, Park M. Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer. Sci Signal. 2014;7:ra38. [PMID: 24757178 DOI: 10.1126/scisignal.2004839] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
178 Emadi-Baygi M, Nikpour P, Emadi-Andani E. SIX1 overexpression in diffuse-type and grade III gastric tumors: Features that are associated with poor prognosis. Adv Biomed Res. 2015;4:139. [PMID: 26322287 DOI: 10.4103/2277-9175.161540] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
179 Nowacki M, Grzanka D, Zegarski W. Pressurized intraperitoneal aerosol chemotheprapy after misdiagnosed gastric cancer: Case report and review of the literature. World J Gastroenterol 2018; 24(19): 2130-2136 [PMID: 29785081 DOI: 10.3748/wjg.v24.i19.2130] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
180 Dicken BJ, Graham K, Hamilton SM, Andrews S, Lai R, Listgarten J, Jhangri GS, Saunders LD, Damaraju S, Cass C. Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg. 2006;243:64-73. [PMID: 16371738 DOI: 10.1097/01.sla.0000194087.96582.3e] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 5.5] [Reference Citation Analysis]
181 Laitinen A, Böckelman C, Hagström J, Kokkola A, Kallio P, Haglund C. High PROX1 expression in gastric cancer predicts better survival. PLoS One 2017;12:e0183868. [PMID: 28854215 DOI: 10.1371/journal.pone.0183868] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
182 Arpalahti L, Laitinen A, Hagström J, Mustonen H, Kokkola A, Böckelman C, Haglund C, Holmberg CI. Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis. PLoS One 2018;13:e0193125. [PMID: 29474458 DOI: 10.1371/journal.pone.0193125] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
183 Zhao E, Zhou C, Chen S. Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer. Clin Res Hepatol Gastroenterol 2021;45:101455. [PMID: 32505732 DOI: 10.1016/j.clinre.2020.04.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
184 Kim HH. Endoscopic Raman Spectroscopy for Molecular Fingerprinting of Gastric Cancer: Principle to Implementation. Biomed Res Int. 2015;2015:670121. [PMID: 26106612 DOI: 10.1155/2015/670121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
185 Kanda M, Shimizu D, Sueoka S, Nomoto S, Oya H, Takami H, Ezaka K, Hashimoto R, Tanaka Y, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Prognostic relevance of SAMSN1 expression in gastric cancer. Oncol Lett 2016;12:4708-16. [PMID: 28105178 DOI: 10.3892/ol.2016.5233] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
186 Zou XM, Li YL, Wang H, Cui W, Li XL, Fu SB, Jiang HC. Gastric cancer cell lines induced by trichostatin A. World J Gastroenterol 2008; 14(30): 4810-4815 [PMID: 18720545 DOI: 10.3748/wjg.14.4810] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
187 Harbour S, Sutton P. Immunogenicity and pathogenicity of Helicobacter infections of veterinary animals. Vet Immunol Immunopathol 2008;122:191-203. [PMID: 18243338 DOI: 10.1016/j.vetimm.2007.12.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
188 Krzysiek-Maczka G, Targosz A, Szczyrk U, Wrobel T, Strzalka M, Brzozowski T, Czyz J, Ptak-Belowska A. Long-Term Helicobacter pylori Infection Switches Gastric Epithelium Reprogramming Towards Cancer Stem Cell-Related Differentiation Program in Hp-Activated Gastric Fibroblast-TGFβ Dependent Manner.Microorganisms. 2020;8. [PMID: 33023180 DOI: 10.3390/microorganisms8101519] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
189 d'Errico M, Alwers E, Zhang Y, Edelmann D, Brenner H, Hoffmeister M. Identification of prognostic DNA methylation biomarkers in patients with gastrointestinal adenocarcinomas: A systematic review of epigenome-wide studies. Cancer Treatment Reviews 2020;82:101933. [DOI: 10.1016/j.ctrv.2019.101933] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
190 Bang GA, Savom EP, Oumarou BN, Ngamy CKM, Moto GB, Boukar YME, Binyom PR, Essomba A, Sosso MA. Clinical epidemiology and mortality risk factors of gastric cancer in a sub-Saharan African setting: a retrospective analysis of 120 cases in Yaoundé (Cameroon). Pan Afr Med J 2020;37:104. [PMID: 33425137 DOI: 10.11604/pamj.2020.37.104.25422] [Reference Citation Analysis]
191 Wong HH, Chu P. Immunohistochemical features of the gastrointestinal tract tumors. J Gastrointest Oncol 2012;3:262-84. [PMID: 22943017 DOI: 10.3978/j.issn.2078-6891.2012.019] [Cited by in F6Publishing: 31] [Reference Citation Analysis]
192 Sun Y, Guo B, Xu L, Zhong J, Liu Z, Liang H, Wen N, Yun W, Zhang L, Zhao X. Stat3-siRNA inhibits the growth of gastric cancer in vitro and in vivo: Stat3-siRNA Inhibits Gastric Cancer Growth. Cell Biochem Funct 2015;33:495-502. [DOI: 10.1002/cbf.3148] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
193 Ribeiro MC, Lopes LR, Coelho Neto Jde S, Tercioti V Jr, Andreollo NA. Gastric adenocarcinoma after gastric bypass for morbid obesity: a case report and review of the literature. Case Rep Med 2013;2013:609727. [PMID: 23509467 DOI: 10.1155/2013/609727] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
194 Fuccio L, Eusebi LH, Bazzoli F. Gastric cancer, Helicobacter pylori infection and other risk factors. World J Gastrointest Oncol 2010; 2(9): 342-347 [PMID: 21160805 DOI: 10.4251/wjgo.v2.i9.342] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
195 Thongbai B, Rapior S, Hyde KD, Wittstein K, Stadler M. Hericium erinaceus, an amazing medicinal mushroom. Mycol Progress 2015;14. [DOI: 10.1007/s11557-015-1105-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 31] [Article Influence: 9.2] [Reference Citation Analysis]
196 Wu Y, Grabsch H, Ivanova T, Tan IB, Murray J, Ooi CH, Wright AI, West NP, Hutchins GG, Wu J, Lee M, Lee J, Koo JH, Yeoh KG, van Grieken N, Ylstra B, Rha SY, Ajani JA, Cheong JH, Noh SH, Lim KH, Boussioutas A, Lee JS, Tan P. Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer. Gut 2013;62:1100-11. [PMID: 22735568 DOI: 10.1136/gutjnl-2011-301373] [Cited by in Crossref: 98] [Cited by in F6Publishing: 95] [Article Influence: 10.9] [Reference Citation Analysis]
197 Rymbai ML, Ramalingam VV, Samarasan I, Chandran BS, Mathew G, Jerobin J, Abraham AM, Sachithanandham J, Kannangai R. Frequency of Epstein--Barr virus infection as detected by messenger RNA for EBNA 1 in histologically proven gastric adenocarcinoma in patients presenting to a tertiary care center in South India. Indian J Med Microbiol 2015;33:369-73. [PMID: 26068337 DOI: 10.4103/0255-0857.158556] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
198 Engin AB, Karahalil B, Engin A, Karakaya AE. DNA repair enzyme polymorphisms and oxidative stress in a Turkish population with gastric carcinoma. Mol Biol Rep 2011;38:5379-86. [PMID: 21390502 DOI: 10.1007/s11033-011-0690-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
199 Omar OM, Soutto M, Bhat NS, Bhat AA, Lu H, Chen Z, El-Rifai W. TFF1 antagonizes TIMP-1 mediated proliferative functions in gastric cancer. Mol Carcinog 2018;57:1577-87. [PMID: 30035371 DOI: 10.1002/mc.22880] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
200 Arévalo-Romero H, Meza I, Vallejo-Flores G, Fuentes-Pananá EM. Helicobacter pylori CagA and IL-1β Promote the Epithelial-to-Mesenchymal Transition in a Nontransformed Epithelial Cell Model. Gastroenterol Res Pract 2016;2016:4969163. [PMID: 27525003 DOI: 10.1155/2016/4969163] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
201 Han F, Zhang L, Qiu W, Yi X. TRAF6 promotes the invasion and metastasis and predicts a poor prognosis in gastric cancer. Pathol Res Pract 2016;212:31-7. [PMID: 26627263 DOI: 10.1016/j.prp.2015.11.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
202 Lin JX, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, and Lu J, Laparoscopy-assisted gastrectomy with D2 lymph node dissection for advanced gastric cancer without serosa invasion: a matched cohort study from South China World J Surg Oncol. 2013;11:4. [PMID: 23311966 DOI: 10.1186/1477-7819-11-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
203 Wang Z, Tang X, Wu X, Yang M, Wang W, Wang L, Tang D, Wang D. Cardamonin exerts anti-gastric cancer activity via inhibiting LncRNA-PVT1-STAT3 axis. Biosci Rep 2019;39:BSR20190357. [PMID: 31028131 DOI: 10.1042/BSR20190357] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
204 Tan E, Lam S, Han SP, Storey D, Sandroussi C. Perioperative outcomes and survival in elderly patients aged ≥ 75 years undergoing gastrectomy for gastric cancer: an 18-year retrospective analysis in a single Western centre. Langenbecks Arch Surg 2021;406:1057-69. [PMID: 33770264 DOI: 10.1007/s00423-021-02116-w] [Reference Citation Analysis]
205 Hsiao YJ, Wen YC, Lai WY, Lin YY, Yang YP, Chien Y, Yarmishyn AA, Hwang DK, Lin TC, Chang YC, Lin TY, Chang KJ, Chiou SH, Jheng YC. Application of artificial intelligence-driven endoscopic screening and diagnosis of gastric cancer. World J Gastroenterol 2021; 27(22): 2979-2993 [PMID: 34168402 DOI: 10.3748/wjg.v27.i22.2979] [Reference Citation Analysis]
206 Marchesi F, De Sario G, Cecchini S, Tartamella F, Riccò M, Romboli A. Laparoscopic subtotal gastrectomy for the treatment of advanced gastric cancer: a comparison with open procedure at the beginning of the learning curve. Acta Biomed 2017;88:302-9. [PMID: 29083335 DOI: 10.23750/abm.v88i3.6541] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
207 Jang YJ, Park MS, Kim JH, Park SS, Park SH, Kim SJ, Kim CS, Mok YJ. Advanced gastric cancer in the middle one-third of the stomach: Should surgeons perform total gastrectomy? J Surg Oncol. 2010;101:451-456. [PMID: 19924722 DOI: 10.1002/jso.21431] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
208 Li Z, Yu Y, Lu J, Luo Q, Wu C, Liao M, Zheng Y, Ai X, Gu L, Lu S. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China. J Thorac Oncol 2009;4:702-9. [PMID: 19404215 DOI: 10.1097/JTO.0b013e3181a5269d] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
209 Liu Y, Zhang J, Yu W, Zhang X, Wang G, Zhao Z. Dapper homolog 1 alpha suppresses metastasis ability of gastric cancer through inhibiting planar cell polarity pathway. Oncotarget 2016;7:81423-34. [PMID: 27833078 DOI: 10.18632/oncotarget.13234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
210 Pandi NS, Suganya S, Rajendran S. In silico analysis of stomach lineage specific gene set expression pattern in gastric cancer. Biochemical and Biophysical Research Communications 2013;439:539-46. [DOI: 10.1016/j.bbrc.2013.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
211 Pinheiro H, Oliveira C, Seruca R, Carneiro F. Hereditary diffuse gastric cancer - pathophysiology and clinical management. Best Pract Res Clin Gastroenterol. 2014;28:1055-1068. [PMID: 25439071 DOI: 10.1016/j.bpg.2014.09.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
212 Deng J, Liang H, Ying G, Zhang R, Wang B, Yu J, Fan D, Hao X. Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer. Oncotarget 2014;5:3173-83. [PMID: 24833402 DOI: 10.18632/oncotarget.1888] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
213 Huang M, Chen Z, Wei B, Zhang B, Wang C, Huang M, Liu R, Tang C. Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide. Acta Pharmacol Sin 2007;28:1842-50. [DOI: 10.1111/j.1745-7254.2007.00652.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
214 Lee JW, Ali B, Yoo HM, Park CH, Song KY. Conditional survival analysis in Korean patients with gastric cancer undergoing curative gastrectomy. BMC Cancer 2015;15:1005. [PMID: 26699710 DOI: 10.1186/s12885-015-2022-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
215 Jagric T, Potrc S, Jagric T. Prediction of liver metastases after gastric cancer resection with the use of learning vector quantization neural networks. Dig Dis Sci. 2010;55:3252-3261. [PMID: 20186483 DOI: 10.1007/s10620-010-1155-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
216 Eivaz-Mohammadi S, Gonzalez-Ibarra F, Abdul W, Tarar O, Malik K, Syed AK. Her2+ and b-HCG Producing Undifferentiated Gastric Adenocarcinoma. Case Rep Med 2014;2014:268919. [PMID: 25349615 DOI: 10.1155/2014/268919] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
217 Kang G, Hwang WC, Do IG, Wang K, Kang SY, Lee J, Park SH, Park JO, Kang WK, Jang J, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Kim MJ, Kim S, Park CK, Kim KM. Exome sequencing identifies early gastric carcinoma as an early stage of advanced gastric cancer. PLoS One 2013;8:e82770. [PMID: 24376576 DOI: 10.1371/journal.pone.0082770] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
218 Lu J, Yin Y, Du M, Ma G, Ge Y, Zhang Q, Chu H, Tong N, Wang M, Qiu J, Zhang Z. The association analysis of hOGG1 genetic variants and gastric cancer risk in a Chinese population. Oncotarget 2016;7:66061-8. [PMID: 27603140 DOI: 10.18632/oncotarget.11802] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
219 Hu J, Fang Y, Cao Y, Qin R, Chen Q. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells. Dig Dis Sci. 2014;59:336-345. [PMID: 24248414 DOI: 10.1007/s10620-013-2923-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
220 Cho SJ, Choi IJ, Kook MC, Nam BH, Kim CG, Lee JY, Ryu KW, Kim YW. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems. Aliment Pharmacol Ther. 2013;38:1292-1302. [PMID: 24134499 DOI: 10.1111/apt.12515] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
221 Mocellin S, Pasquali S. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane Database Syst Rev. 2015;CD009944. [PMID: 25914908 DOI: 10.1002/14651858.cd009944.pub2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 8.5] [Reference Citation Analysis]
222 Scartozzi M, Loretelli C, Bearzi I, Mandolesi A, Galizia E, Onofri A, Pistelli M, Bittoni A, Berardi R, Cascinu S. Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. Ann Oncol 2011;22:897-902. [PMID: 20926544 DOI: 10.1093/annonc/mdq542] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
223 Xu CY, Guo JL, Jiang ZN, Xie SD, Shen JG, Shen JY, Wang LB. Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer. Ann Surg Oncol. 2010;17:2503-2509. [PMID: 20339947 DOI: 10.1245/s10434-010-1031-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
224 Cui HB, Ge HE, Bai XY, Zhang W, Zhang YY, Wang J, Li X, Xing LP, Guo SH, Wang ZY. Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer. Exp Ther Med 2014;7:1083-8. [PMID: 24940391 DOI: 10.3892/etm.2014.1599] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
225 Wu X, Shen J, Xiao Z, Li J, Zhao Y, Zhao Q, Cho CH, Li M. An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets. Biochem Pharmacol 2019;163:425-39. [PMID: 30857828 DOI: 10.1016/j.bcp.2019.03.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
226 Burgazli KM, Mericliler M, Kavukcu E, Erdogan A, Ertan AK. Discovery of asymptomatic Krukenberg tumors diagnosed during caesarean section: therapy with hyperthermic intraperitoneal chemotherapy. Postgrad Med 2013;125:87-90. [PMID: 23933897 DOI: 10.3810/pgm.2013.07.2681] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
227 Oñate-Ocaña LF, Aiello-Crocifoglio V, Gallardo-Rincón D, Herrera-Goepfert R, Brom-Valladares R, Carrillo JF, Cervera E, Mohar-Betancourt A. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol 2007;14:381-9. [PMID: 17160496 DOI: 10.1245/s10434-006-9093-x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 110] [Article Influence: 7.4] [Reference Citation Analysis]
228 Souma Y, Nishida T, Serada S, Iwahori K, Takahashi T, Fujimoto M, Ripley B, Nakajima K, Miyazaki Y, Mori M, Doki Y, Sawa Y, Naka T. Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells. Int J Cancer 2012;131:1287-96. [DOI: 10.1002/ijc.27350] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
229 Chen XZ, Zhang WH, Chen XL, Liu K, Yang K, Zhou ZG, Hu JK. Upper lesser curvature skeletonization in radical distal gastrectomy. J Surg Res 2015;193:168-75. [PMID: 25145906 DOI: 10.1016/j.jss.2014.07.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
230 Chen Y, Chen G, Zheng X, He C, Feng S, Chen Y, Lin X, Chen R, Zeng H. Discrimination of gastric cancer from normal by serum RNA based on surface-enhanced Raman spectroscopy (SERS) and multivariate analysis. Med Phys. 2012;39:5664-5668. [PMID: 22957632 DOI: 10.1118/1.4747269] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
231 Liao G, Chen J, Ren C, Li R, Du S, Xie G, Deng H, Yang K, Yuan Y. Robotic versus open gastrectomy for gastric cancer: a meta-analysis. PLoS One 2013;8:e81946. [PMID: 24312610 DOI: 10.1371/journal.pone.0081946] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
232 Tsai CK, Yeh TS, Wu RC, Lai YC, Chiang MH, Lu KY, Hung CY, Ho HY, Cheng ML, Lin G. Metabolomic alterations and chromosomal instability status in gastric cancer. World J Gastroenterol 2018; 24(33): 3760-3769 [PMID: 30197481 DOI: 10.3748/wjg.v24.i33.3760] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
233 Sun Z, Xu Y, Li de M, Wang ZN, Zhu GL, Huang BJ, Li K, Xu HM. Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer. 2010;116:2571-2580. [PMID: 20336791 DOI: 10.1002/cncr.24989] [Cited by in Crossref: 96] [Cited by in F6Publishing: 113] [Article Influence: 8.7] [Reference Citation Analysis]
234 Sun Z, Li DM, Wang ZN, Huang BJ, Xu Y, Li K, Xu HM. Prognostic significance of microscopic positive margins for gastric cancer patients with potentially curative resection. Ann Surg Oncol. 2009;16:3028-3037. [PMID: 19626373 DOI: 10.1245/s10434-009-0624-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
235 Schumacher SE, Shim BY, Corso G, Ryu MH, Kang YK, Roviello F, Saksena G, Peng S, Shivdasani RA, Bass AJ, Beroukhim R. Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients. PLoS One 2017;12:e0176045. [PMID: 28426752 DOI: 10.1371/journal.pone.0176045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
236 Wang H, Chen MM, Zhu GS, Ma MG, Du HS, Long YP. Lymph node mapping with carbon nanoparticles and the risk factors of lymph node metastasis in gastric cancer. J Huazhong Univ Sci Technolog Med Sci. 2016;36:865-870. [PMID: 27924502 DOI: 10.1007/s11596-016-1676-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
237 Payet E, Pilco PI, Montes J, Cordero-Morales A, Savitzky MJ, Stenning-Persivale K. Collision tumour of large-cell neuroendocrine carcinoma and adenocarcinoma in the stomach: A case report. Ecancermedicalscience 2016;10:616. [PMID: 26913067 DOI: 10.3332/ecancer.2016.616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
238 Abrahão-Machado LF, Jácome AADA, Wohnrath DR, Santos JSD, Carneseca EC, Fregnani JHTG, Scapulatempo-Neto C. HER2 in gastric cancer: Comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays. World J Gastroenterol 2013; 19(38): 6438-6446 [PMID: 24151362 DOI: 10.3748/wjg.v19.i38.6438] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
239 Azagra JS, Goergen M, Lens V, Ibáñez-aguirre JF, Schiltz M, Siciliano I. Present state of the Mini-Invasive Surgery (MIS) in esophageal and gastric cancer. Clin Transl Oncol 2006;8:173-7. [DOI: 10.1007/s12094-006-0007-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
240 Arigami T, Uenosono Y, Hirata M, Yanagita S, Ishigami S, Natsugoe S. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci. 2011;102:1019-1024. [PMID: 21251161 DOI: 10.1111/j.1349-7006.2011.01877.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 5.6] [Reference Citation Analysis]
241 Shulman K, Haim N, Wollner M, Bernstein Z, Abdah-Bortnyak R, Bar-Sela G. Postoperative chemotherapy in gastric cancer, consisting of etoposide, doxorubicin and cisplatin, followed by radiotherapy with concomitant cisplatin: A feasibility study. Oncol Lett 2012;3:1154-8. [PMID: 22783410 DOI: 10.3892/ol.2012.617] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
242 Patrad E, Niapour A, Farassati F, Amani M. Combination treatment of all-trans retinoic acid (ATRA) and γ-secretase inhibitor (DAPT) cause growth inhibition and apoptosis induction in the human gastric cancer cell line. Cytotechnology 2018;70:865-77. [PMID: 29417442 DOI: 10.1007/s10616-018-0199-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
243 Kanda M, Mizuno A, Fujii T, Shimoyama Y, Yamada S, Tanaka C, Kobayashi D, Koike M, Iwata N, Niwa Y. Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer. Ann Surg Oncol. 2016;23:1934-1940. [PMID: 26847679 DOI: 10.1245/s10434-016-5102-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
244 Korbakis D, Fragoulis EG, Scorilas A. Quantification and study of the L-DOPA decarboxylase expression in gastric adenocarcinoma cells treated with chemotherapeutic substances. Anticancer Drugs 2013;24:291-9. [PMID: 23328075 DOI: 10.1097/CAD.0b013e32835db25a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
245 Koskensalo S, Mrena J, Wiksten JP, Nordling S, Kokkola A, Hagström J, Haglund C. MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biol. 2010;31:149-155. [PMID: 20300917 DOI: 10.1007/s13277-010-0020-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
246 Leandro-merhi VA, Tristão AP, Moretto MC, Fugulin NM, Portero-mclellan KC, Aquino JLBD. Estudo comparativo de indicadores nutricionais em pacientes com neoplasias do trato digestório. ABCD, arq bras cir dig 2008;21:114-9. [DOI: 10.1590/s0102-67202008000300004] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
247 Pandey A, Tripathi SC, Mahata S, Vishnoi K, Shukla S, Misra SP, Misra V, Hedau S, Mehrotra R, Dwivedi M, Bharti AC. Carcinogenic Helicobacter pylori in gastric pre-cancer and cancer lesions: Association with tobacco-chewing. World J Gastroenterol 2014; 20(22): 6860-6868 [PMID: 24944476 DOI: 10.3748/wjg.v20.i22.6860] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
248 Becker K, Reim D, Novotny A, Zum Büschenfelde CM, Engel J, Friess H, Höfler H, Langer R. Proposal for a multifactorial prognostic score that accurately classifies 3 groups of gastric carcinoma patients with different outcomes after neoadjuvant chemotherapy and surgery. Ann Surg. 2012;256:1002-1007. [PMID: 22968067 DOI: 10.1097/sla.0b013e318262a591] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
249 Xie N, Pan Y, Wu J, Bai Y, Xiao C, Gao X, Wang J, Liu N. MicroRNA-302s Might Regulate ARL4C-Mediated Gastric Cancer Progression via p53 Signaling: Bioinformatics Analysis and Experiments Validation. Onco Targets Ther 2021;14:2541-53. [PMID: 33880033 DOI: 10.2147/OTT.S282992] [Reference Citation Analysis]
250 Li P, Hu J, Shi B, Tie J. Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway. Biochem Biophys Res Commun 2020;531:320-7. [PMID: 32800561 DOI: 10.1016/j.bbrc.2020.07.045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
251 Santos RS, Dakwar GR, Xiong R, Forier K, Remaut K, Stremersch S, Guimarães N, Fontenete S, Wengel J, Leite M, Figueiredo C, De Smedt SC, Braeckmans K, Azevedo NF. Effect of Native Gastric Mucus on in vivo Hybridization Therapies Directed at Helicobacter pylori. Mol Ther Nucleic Acids 2015;4:e269. [PMID: 26645765 DOI: 10.1038/mtna.2015.46] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
252 Liu K, Qian T, Tang L, Wang J, Yang H, Ren J. Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer. World J Surg Oncol. 2012;10:225. [PMID: 23107361 DOI: 10.1186/1477-7819-10-225] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
253 Gu L, Liu L, Zhong L, Bai Y, Sui H, Wei X, Zhang W, Huang P, Gao D, Kong Y, Lou G. Cthrc1 overexpression is an independent prognostic marker in gastric cancer. Hum Pathol. 2014;45:1031-1038. [PMID: 24746208 DOI: 10.1016/j.humpath.2013.12.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
254 Zhao J, Nie Y, Wang H, Lin Y. MiR-181a suppresses autophagy and sensitizes gastric cancer cells to cisplatin. Gene. 2016;576:828-833. [PMID: 26589846 DOI: 10.1016/j.gene.2015.11.013] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 9.7] [Reference Citation Analysis]
255 Hargunani R, Maclachlan J, Kaniyur S, Power N, Pereira SP, Malhotra A. Cross-sectional imaging of gastric neoplasia. Clin Radiol. 2009;64:420-429. [PMID: 19264188 DOI: 10.1016/j.crad.2008.09.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
256 Castro F, Shahal D, Tarajia M, Velásquez IM, Causadias MT, Herrera V, Gómez B, Cukier M, Motta J. Baseline characteristics, survival and direct costs associated to treatment of gastric cancer patients at the National Oncology Institute of Panama from 2012 to 2015: a hospital-based observational study. BMJ Open 2017;7:e017266. [PMID: 28947456 DOI: 10.1136/bmjopen-2017-017266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
257 Zhang YZ, Zhang LH, Gao Y, Li CH, Jia SQ, Liu N, Cheng F, Niu DY, Cho WC, Ji JF, Zeng CQ. Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling. World J Gastroenterol 2011; 17(13): 1710-1717 [PMID: 21483631 DOI: 10.3748/wjg.v17.i13.1710] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
258 Yao J, Yang Z, Chen H, Chen T, Huang J. Gastric adenocarcinoma: can perfusion CT help to noninvasively evaluate tumor angiogenesis? Abdom Imaging 2011;36:15-21. [DOI: 10.1007/s00261-010-9609-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
259 Zhang Q, Qian Y, Yin Y. Comparison of S-1-based vs. capecitabine-based adjuvant chemotherapy for patients with gastric cancer: a systematic review and meta-analysis. Eur J Clin Pharmacol 2021. [PMID: 34275019 DOI: 10.1007/s00228-021-03187-w] [Reference Citation Analysis]
260 Wisnieski F, Leal MF, Calcagno DQ, Santos LC, Gigek CO, Chen ES, Artigiani R, Demachki S, Assumpção PP, Lourenço LG, Burbano RR, Smith MC. BMP8B Is a Tumor Suppressor Gene Regulated by Histone Acetylation in Gastric Cancer. J Cell Biochem 2017;118:869-77. [PMID: 27748538 DOI: 10.1002/jcb.25766] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
261 Hyung WJ, Kim SS, Choi WH, Cheong JH, Choi SH, Kim CB, Noh SH. Changes in treatment outcomes of gastric cancer surgery over 45 years at a single institution. Yonsei Med J. 2008;49:409-415. [PMID: 18581590 DOI: 10.3349/ymj.2008.49.3.409] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
262 Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep. 2012;27:1019-1026. [PMID: 22267008 DOI: 10.3892/or.2012.1645] [Cited by in Crossref: 182] [Cited by in F6Publishing: 180] [Article Influence: 20.2] [Reference Citation Analysis]
263 Margolin G, Petrykowska HM, Jameel N, Bell DW, Young AC, Elnitski L. Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development. J Mol Diagn 2016;18:283-98. [PMID: 26857064 DOI: 10.1016/j.jmoldx.2015.11.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
264 Sutton P. Considering Increased Mouse Stomach Mass When Calculating Prophylactic Vaccine Efficacy Against Helicobacter pylori. Helicobacter 2007;12:210-2. [DOI: 10.1111/j.1523-5378.2007.00494.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
265 Nitti D, Mocellin S, Marchet A, Pilati P, Lise M. Recent advances in conventional and molecular prognostic factors for gastric carcinoma. Surg Oncol Clin N Am 2008;17:467-83, vii. [PMID: 18486878 DOI: 10.1016/j.soc.2008.02.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
266 Rowe SP, Chu LC, Fishman EK. Evaluation of Stomach Neoplasms With 3-Dimensional Computed Tomography: Focus on the Potential Role of Cinematic Rendering. Journal of Computer Assisted Tomography 2018;42:661-6. [DOI: 10.1097/rct.0000000000000761] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 3.7] [Reference Citation Analysis]
267 Subbannayya Y, Syed N, Barbhuiya MA, Raja R, Marimuthu A, Sahasrabuddhe N, Pinto SM, Manda SS, Renuse S, Manju HC, Zameer MA, Sharma J, Brait M, Srikumar K, Roa JC, Vijaya Kumar M, Kumar KV, Prasad TS, Ramaswamy G, Kumar RV, Pandey A, Gowda H, Chatterjee A. Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma. Cancer Biol Ther 2015;16:336-45. [PMID: 25756516 DOI: 10.4161/15384047.2014.972264] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
268 Yan JF, Kim H, Jeong SK, Lee HJ, Sethi MK, Lee LY, Beavis RC, Im H, Snyder MP, Hofree M, Ideker T, Wu SL, Paik YK, Fanayan S, Hancock WS. Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues. J Proteome Res 2015;14:4995-5006. [PMID: 26435392 DOI: 10.1021/acs.jproteome.5b00827] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
269 Park HS, Kim HS, Beom SH, Rha SY, Chung HC, Kim JH, Chun YJ, Lee SW, Choe EA, Heo SJ, Noh SH, Hyung WJ, Cheong JH, Kim HI, Son T, Lim JS, Baek SE, Jung M. Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial. Ann Surg Oncol 2018;25:3222-30. [PMID: 30051367 DOI: 10.1245/s10434-018-6624-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
270 Boers JE, Meeuwissen H, Methorst N. HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH). Histopathology. 2011;58:383-394. [PMID: 21323962 DOI: 10.1111/j.1365-2559.2011.03760.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]
271 Ziqiang W, Feng Q, Zhimin C, Miao W, Lian Q, Huaxing L, Peiwu Y. Comparison of laparoscopically assisted and open radical distal gastrectomy with extended lymphadenectomy for gastric cancer management. Surg Endosc. 2006;20:1738-1743. [PMID: 17024529 DOI: 10.1007/s00464-006-0031-6] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
272 Ruhaak LR, Barkauskas DA, Torres J, Cooke CL, Wu LD, Stroble C, Ozcan S, Williams CC, Camorlinga M, Rocke DM. The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer. EuPA Open Proteom. 2015;6:1-9. [PMID: 25685702 DOI: 10.1016/j.euprot.2014.11.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
273 Signal V, Gurney J, Inns S, Mcleod M, Sika-paotonu D, Sowerbutts S, Teng A, Sarfati D. Helicobacter pylori , stomach cancer and its prevention in New Zealand. Journal of the Royal Society of New Zealand 2020;50:397-417. [DOI: 10.1080/03036758.2019.1650081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
274 Ye Z, Zheng M, Zeng Y, Wei S, Huang H, Wang Y, Liu Q, Lin Z, Chen S, Zheng Q, Chen L. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma. Front Oncol 2021;11:612952. [PMID: 34235071 DOI: 10.3389/fonc.2021.612952] [Reference Citation Analysis]
275 Rivas-Ortiz CI, Lopez-Vidal Y, Arredondo-Hernandez LJR, Castillo-Rojas G. Genetic Alterations in Gastric Cancer Associated with <i>Helicobacter pylori</i> Infection. Front Med (Lausanne). 2017;4:47. [PMID: 28512631 DOI: 10.3389/fmed.2017.00047] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
276 Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 2018;10:239-48. [PMID: 29445300 DOI: 10.2147/CMAR.S149619] [Cited by in Crossref: 339] [Cited by in F6Publishing: 218] [Article Influence: 113.0] [Reference Citation Analysis]
277 Araki I, Hosoda K, Yamashita K, Katada N, Sakuramoto S, Moriya H, Mieno H, Ema A, Kikuchi S, Mikami T. Prognostic impact of venous invasion in stage IB node-negative gastric cancer. Gastric Cancer. 2015;18:297-305. [PMID: 24687437 DOI: 10.1007/s10120-014-0362-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
278 Sutton P, Chionh YT. Why can’t we make an effective vaccine against Helicobacter pylori? Expert Rev Vaccines. 2013;12:433-441. [PMID: 23560923 DOI: 10.1586/erv.13.20] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
279 Wang J, Yu JC, Kang WM, Ma ZQ. Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer. J Surg Oncol. 2012;105:400-404. [PMID: 22311818 DOI: 10.1002/jso.22089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
280 Tiberio GA, Baiocchi GL, Morgagni P, Marrelli D, Marchet A, Cipollari C, Graziosi L, Ministrini S, Vittimberga G, Donini A, Nitti D, Roviello F, Coniglio A, de Manzoni G. Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection? Ann Surg Oncol. 2015;22:589-596. [PMID: 25190117 DOI: 10.1245/s10434-014-4018-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
281 Martella L, Bertozzi S, Londero AP, Steffan A, De Paoli P, Bertola G. Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies. Medicine (Baltimore). 2015;94:e1113. [PMID: 26252272 DOI: 10.1097/md0000000000001113] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
282 Vahid F, Rahmani D, Davoodi SH. Validation of Dietary Antioxidant Index (DAI) and investigating the relationship between DAI and the odds of gastric cancer. Nutr Metab (Lond) 2020;17:102. [PMID: 33292344 DOI: 10.1186/s12986-020-00529-w] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
283 Sha S, Gu Y, Xu B, Hu H, Yang Y, Kong X, Wu K. Decreased expression of HOXB9 is related to poor overall survival in patients with gastric carcinoma. Dig Liver Dis 2013;45:422-9. [PMID: 23332081 DOI: 10.1016/j.dld.2012.12.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
284 Qi Y, Zhang X, Kang Y, Wu J, Chen J, Li H, Guo Y, Liu B, Shao Z, Zhao X. Genome-wide transcriptional profiling analysis reveals annexin A6 as a novel EZH2 target gene involving gastric cellular proliferation. Mol Biosyst 2015;11:1980-6. [PMID: 25947258 DOI: 10.1039/c5mb00233h] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
285 Liu D, Zhang L, Shen Z, Tan F, Hu Y, Yu J, Li G. Clinicopathological significance of NMIIA Overexpression in Human Gastric Cancer. Int J Mol Sci. 2012;13:15291-15304. [PMID: 23203126 DOI: 10.3390/ijms131115291] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
286 Xu JD, Furuya T, Cao XX, Liu XL, Li QQ, Wang WJ, Xu JW, Xu ZD, Sasaki K, Liu XP. Loss of BCL2L10 protein expression as prognostic predictor for poor clinical outcome in gastric carcinoma: BCL2L10, prognosis of gastric carcinoma. Histopathology 2010;57:814-24. [DOI: 10.1111/j.1365-2559.2010.03720.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
287 Armero VES, Tremblay MP, Allaire A, Boudreault S, Martenon-Brodeur C, Duval C, Durand M, Lapointe E, Thibault P, Tremblay-Létourneau M, Perreault JP, Scott MS, Bisaillon M. Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas. PLoS One 2017;12:e0176880. [PMID: 28493890 DOI: 10.1371/journal.pone.0176880] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
288 Safaralizadeh R, Ajami N, Nemati M, Hosseinpourfeizi M, Azimzadeh Isfanjani A, Moaddab SY. Disregulation of miR-216a and miR-217 in Gastric Cancer and Their Clinical Significance. J Gastrointest Cancer 2019;50:78-83. [PMID: 29177609 DOI: 10.1007/s12029-017-0019-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
289 Sun X, Lin J, Ju A. Treatment of Borrmann Type IV Gastric Cancer with a Neoadjuvant Chemotherapy Combination of Docetaxel, Cisplatin and 5-Fluorouracil/Leucovorin. J Int Med Res 2011;39:2096-102. [DOI: 10.1177/147323001103900605] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
290 Riquelme I, Saavedra K, Espinoza JA, Weber H, García P, Nervi B, Garrido M, Corvalán AH, Roa JC, Bizama C. Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. Oncotarget 2015;6:24750-79. [PMID: 26267324 DOI: 10.18632/oncotarget.4990] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 15.6] [Reference Citation Analysis]
291 Akturk OM, Çakir M. Red Cell Distribution Width as a Predictor of Malignancy in Patients Who Underwent Upper Gastrointestinal System Endoscopy. Int J Appl Basic Med Res 2020;10:200-4. [PMID: 33088744 DOI: 10.4103/ijabmr.IJABMR_329_19] [Reference Citation Analysis]
292 Yu HF, Zhao G, Ge ZJ, Wang DR, Chen J, Zhang Y, Zha TZ, Zhang K, Zhang M, Tan YF. High RIN1 expression is associated with poor prognosis in patients with gastric adenocarcinoma. Tumour Biol. 2012;33:1557-1563. [PMID: 22562267 DOI: 10.1007/s1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
293 Skene CD, Doidge C, Sutton P. Evaluation of ISCOMATRIX™ and ISCOM™ vaccines for immunisation against Helicobacter pylori. Vaccine 2008;26:3880-4. [DOI: 10.1016/j.vaccine.2008.05.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
294 Moss DM, Curley P, Kinvig H, Hoskins C, Owen A. The biological challenges and pharmacological opportunities of orally administered nanomedicine delivery. Expert Rev Gastroenterol Hepatol 2018;12:223-36. [PMID: 29088978 DOI: 10.1080/17474124.2018.1399794] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
295 Bu Z, Zheng Z, Li Z, Zhang L, Wu A, Wu X, Sun Y, Ji J. Lymphatic vascular invasion is an independent correlated factor for lymph node metastasis and the prognosis of resectable T2 gastric cancer patients. Tumour Biol. 2013;34:1005-1012. [PMID: 23292920 DOI: 10.1007/s13277-012-0637-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
296 Santos RS, Lourenço JE, Herbella FA, Del Grande JC, Patti MG. Helicobacter pylori has no influence on distal gastric cancer survival. Arq Gastroenterol 2011;48:109-11. [PMID: 21709951 DOI: 10.1590/s0004-28032011000200005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
297 Vidal O, Soriano-Izquierdo A, Pera M, Elizalde JI, Palacín A, Castells A, Piqué JM, Volant A, Metges JP. Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers. J Gastrointest Surg. 2008;12:1005-1014. [PMID: 17972143 DOI: 10.1007/s11605-007-0336-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
298 Grillo F, Fassan M, Ceccaroli C, Giacometti C, Curto M, Zagonel V, Ceppa P, Nitti D, Castoro C, Fiocca R, Rugge M, Mastracci L. The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples. Transl Oncol 2013;6:10-6. [PMID: 23418612 DOI: 10.1593/tlo.12334] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
299 Wang J, Zhang J, Wu J, Luo D, Su K, Shi W, Liu J, Tian Y, Wei L. MicroRNA-610 inhibits the migration and invasion of gastric cancer cells by suppressing the expression of vasodilator-stimulated phosphoprotein. Eur J Cancer. 2012;48:1904-1913. [PMID: 22189055 DOI: 10.1016/j.ejca.2011.11.026] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
300 Baj J, Brzozowska K, Forma A, Maani A, Sitarz E, Portincasa P. Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis. Int J Mol Sci 2020;21:E2544. [PMID: 32268527 DOI: 10.3390/ijms21072544] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
301 Li S, Gao J, Xu Q, Zhang X, Huang M, Dai X, Huang K, Liu L. A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors. Front Immunol 2021;12:693314. [PMID: 34177954 DOI: 10.3389/fimmu.2021.693314] [Reference Citation Analysis]
302 Zhang YJ, Fang JY. Molecular staging of gastric cancer. J Gastroenterol Hepatol 2008;23:856-60. [PMID: 17854423 DOI: 10.1111/j.1440-1746.2007.05140.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
303 Baron HR, Allavena R, Melville LM, Doneley RJ. Gastric adenocarcinoma in a diamond python (Morelia spilota spilota). Aust Vet J 2014;92:405-9. [PMID: 25179427 DOI: 10.1111/avj.12233] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
304 Alpízar-alpízar W, Christensen IJ, Santoni-rugiu E, Skarstein A, Ovrebo K, Illemann M, Laerum OD. Urokinase plasminogen activator receptor on invasive cancer cells: A prognostic factor in distal gastric adenocarcinoma. Int J Cancer 2012;131:E329-36. [DOI: 10.1002/ijc.26417] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
305 Wang J, Yu JC, Kang WM, Wang WZ, Liu YQ, Gu P. The predictive effect of cadherin-17 on lymph node micrometastasis in pN0 gastric cancer. Ann Surg Oncol 2012;19:1529-34. [PMID: 22009269 DOI: 10.1245/s10434-011-2115-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
306 Niu Y, Li JS, Luo XR. Enhancement of expression of survivin promoter-driven CD/TK double suicide genes by the nuclear matrix attachment region in transgenic gastric cancer cells. Gene. 2014;534:177-182. [PMID: 24220851 DOI: 10.1016/j.gene.2013.10.064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
307 Solodova RF, Galatenko VV, Nakashidze ER, Shapovalyants SG, Andreytsev IL, Sokolov ME, Podolskii VE. Instrumental Mechanoreceptoric Palpation in Gastrointestinal Surgery. Minim Invasive Surg 2017;2017:6481856. [PMID: 29464119 DOI: 10.1155/2017/6481856] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
308 Sastre J, García-Saenz JA, Díaz-Rubio E. Chemotherapy for gastric cancer. World J Gastroenterol 2006; 12(2): 204-213 [PMID: 16482619 DOI: 10.3748/wjg.v12.i2.204] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
309 Martinez EZ, Achcar JA, Jácome AA, Santos JS. Mixture and non-mixture cure fraction models based on the generalized modified Weibull distribution with an application to gastric cancer data. Computer Methods and Programs in Biomedicine 2013;112:343-55. [DOI: 10.1016/j.cmpb.2013.07.021] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
310 Shah K, Young L. Epstein–Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clinical Microbiology and Infection 2009;15:982-8. [DOI: 10.1111/j.1469-0691.2009.03033.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
311 Weng DS, Li JT, Mai SJ, Pan ZZ, Feng BJ, Feng QS, Huang LX, Wang QJ, Li YQ, Yu XJ, Chen SP, He J, Xia JC. Identification of a new target region on the long arm of chromosome 7 in gastric carcinoma by loss of heterozygosity. World J Gastroenterol 2006; 12(15): 2437-2440 [PMID: 16688840 DOI: 10.3748/wjg.v12.i15.2437] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
312 Fang J, Ge X, Xu W, Xie J, Qin Z, Shi L, Yin W, Bian M, Wang H. Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer. J Cell Physiol 2020;235:3438-46. [PMID: 31621076 DOI: 10.1002/jcp.29233] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
313 Sampieri CL, Mora M. Gastric cancer research in Mexico: A public health priority. World J Gastroenterol 2014; 20(16): 4491-4502 [PMID: 24782602 DOI: 10.3748/wjg.v20.i16.4491] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
314 de Maat MF, van de Velde CJ, Umetani N, de Heer P, Putter H, van Hoesel AQ, Meijer GA, van Grieken NC, Kuppen PJ, Bilchik AJ. Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. J Clin Oncol. 2007;25:4887-4894. [PMID: 17971584 DOI: 10.1200/jco.2006.09.8921] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
315 Pinheiro C, Longatto-Filho A, Simões K, Jacob CE, Bresciani CJ, Zilberstein B, Cecconello I, Alves VA, Schmitt F, Baltazar F. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer. Eur J Cancer 2009;45:2418-24. [PMID: 19628385 DOI: 10.1016/j.ejca.2009.06.018] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
316 Wang K, Li E, Busuttil RA, Kong JC, Pattison S, Sung JJY, Yu J, El-Omar EM, Simpson JA, Boussioutas A. A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer. Ther Adv Med Oncol 2020;12:1758835920930359. [PMID: 32754227 DOI: 10.1177/1758835920930359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
317 Shah M, Prasad A, Rajan D, Tan CB, Shah M, Raghavan P, Mustacchia P. Direct liver invasion from a gastric adenocarcinoma as an initial presentation of extranodal tumor spread. Case Rep Med 2012;2012:651232. [PMID: 22761626 DOI: 10.1155/2012/651232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
318 Feng B, Xu WB, Zheng MH, Ma JJ, Cai Q, Zhang Y, Ji J, Lu AG, Qu Y, Li JW. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. J Gastroenterol Hepatol. 2006;21:1596-1603. [PMID: 16928223 DOI: 10.1111/j.1440-1746.2006.04228.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
319 Tang L, Zhao S, Liu W, Parchim NF, Huang J, Tang Y, Gan P, Zhong M. Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis. BMC Cancer. 2013;13:314. [PMID: 23806209 DOI: 10.1186/1471-2407-13-314] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
320 Förster S, Gretschel S, Jöns T, Yashiro M, Kemmner W. THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling. Mod Pathol. 2011;24:1390-1403. [PMID: 21701537 DOI: 10.1038/modpathol.2011.99] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
321 Kanda M, Murotani K, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis. Surgery. 2015;158:1573-1580. [PMID: 26120068 DOI: 10.1016/j.surg.2015.05.017] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
322 Mohamed WA, Schaalan MF, Ramadan B. The expression profiling of circulating miR-204, miR-182, and lncRNA H19 as novel potential biomarkers for the progression of peptic ulcer to gastric cancer. J Cell Biochem. 2019;120:13464-13477. [PMID: 30945348 DOI: 10.1002/jcb.28620] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
323 Lombardi PM, Mazzola M, Achilli P, Aquilano MC, De Martini P, Curaba A, Gualtierotti M, Bertoglio CL, Magistro C, Ferrari G. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience. J Surg Oncol 2021;123:923-31. [PMID: 33497471 DOI: 10.1002/jso.26391] [Reference Citation Analysis]
324 Kano K, Yamada T, Yamamoto K, Komori K, Watanabe H, Takahashi K, Maezawa Y, Fujikawa H, Numata M, Aoyama T, Tamagawa H, Cho H, Yukawa N, Yoshikawa T, Rino Y, Masuda M, Ogata T, Oshima T. Evaluation of Lymph Node Staging Systems as Independent Prognosticators in Remnant Gastric Cancer Patients with an Insufficient Number of Harvested Lymph Nodes. Ann Surg Oncol 2021;28:2866-76. [PMID: 33393020 DOI: 10.1245/s10434-020-09433-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
325 Mastoraki A, Benetou C, Mastoraki S, Papanikolaou IS, Danias N, Smyrniotis V, Arkadopoulos N. The role of surgery in the therapeutic approach of gastric cancer liver metastases. Indian J Gastroenterol 2016;35:331-6. [PMID: 27528456 DOI: 10.1007/s12664-016-0683-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
326 Lowe KA, Danese MD, Gleeson ML, Langeberg WJ, Ke J, Kelsh MA. Racial and Ethnic Variability in the Prevalence and Incidence of Comorbidities Associated with Gastric Cancer in the United States. J Gastrointest Cancer 2016;47:168-81. [PMID: 26961791 DOI: 10.1007/s12029-016-9809-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
327 Gümüs-Akay G, Unal AE, Elhan AH, Bayar S, Karadayt K, Sunguroglu A, Kadikiran A, Tükün A. DNA copy number changes in gastric adenocarcinomas: high resolution-comparative genomic hybridization study in Turkey. Arch Med Res 2009;40:551-60. [PMID: 20082868 DOI: 10.1016/j.arcmed.2009.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
328 Nöckel J, van den Engel NK, Winter H, Hatz RA, Zimmermann W, Kammerer R. Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene. BMC Cancer 2006;6:57. [PMID: 16536871 DOI: 10.1186/1471-2407-6-57] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
329 Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE, Ilyas M, Kaur A, Lalloo F, Latchford A, Rutter MD, Tomlinson I, Thomas HJW, Hill J; Hereditary CRC guidelines eDelphi consensus group. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). Gut 2020;69:411-44. [PMID: 31780574 DOI: 10.1136/gutjnl-2019-319915] [Cited by in Crossref: 66] [Cited by in F6Publishing: 48] [Article Influence: 33.0] [Reference Citation Analysis]
330 de la Peña S, Sampieri CL, Ochoa-Lara M, León-Córdoba K, Remes-Troche JM. Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer. Dis Markers 2014;2014:285906. [PMID: 24669030 DOI: 10.1155/2014/285906] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
331 Sakamoto A, Akiyama Y, Shimada S, Zhu WG, Yuasa Y, Tanaka S. DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells. PLoS One 2015;10:e0145630. [PMID: 26695186 DOI: 10.1371/journal.pone.0145630] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
332 Li H, Ma X, Xiao D, Jia Y, Wang Y. Expression of DEC2 enhances chemosensitivity by inhibiting STAT5A in gastric cancer. J Cell Biochem 2018. [PMID: 30485509 DOI: 10.1002/jcb.28131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
333 Tang GH, Hart R, Sholzberg M, Brezden-masley C. Iron deficiency anemia in gastric cancer: a Canadian retrospective review. European Journal of Gastroenterology & Hepatology 2018;30:1497-501. [DOI: 10.1097/meg.0000000000001251] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 3.7] [Reference Citation Analysis]
334 Abuderman AA. Gastric cancer & prospects of cancer in Saudi Arabia peninsula. Saudi J Biol Sci 2019;26:1095-100. [PMID: 31516334 DOI: 10.1016/j.sjbs.2018.02.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
335 Bayoumi AS, Sayed A, Broskova Z, Teoh JP, Wilson J, Su H, Tang YL, Kim IM. Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and Disease. Int J Mol Sci 2016;17:356. [PMID: 26978351 DOI: 10.3390/ijms17030356] [Cited by in Crossref: 137] [Cited by in F6Publishing: 140] [Article Influence: 27.4] [Reference Citation Analysis]
336 Marano A, Choi YY, Hyung WJ, Kim YM, Kim J, Noh SH. Robotic versus Laparoscopic versus Open Gastrectomy: A Meta-Analysis. J Gastric Cancer 2013;13:136-48. [PMID: 24156033 DOI: 10.5230/jgc.2013.13.3.136] [Cited by in Crossref: 79] [Cited by in F6Publishing: 64] [Article Influence: 9.9] [Reference Citation Analysis]
337 Sun P, Xiang JB, Chen ZY. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg. 2009;96:26-33. [PMID: 19016271 DOI: 10.1002/bjs.6408] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
338 Tsutsuyama M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Tumor size  ≥50 mm as an Independent Prognostic Factor for Patients with Stage II or III Gastric Cancer After Postoperative S-1 Monotherapy: Analysis of a Multi-institution Dataset. World J Surg 2020;44:194-201. [PMID: 31552460 DOI: 10.1007/s00268-019-05198-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
339 Kim HS, Lee JH, Park HS, Lee GS, Kim HW, Ha K, Kim BJ. Schizandra chinensis extracts induce apoptosis in human gastric cancer cells via JNK/p38 MAPK activation and the ROS-mediated/mitochondria-dependent pathway. Pharmaceutical Biology 2014;53:212-9. [DOI: 10.3109/13880209.2014.913297] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
340 Vecchi M, Nuciforo P, Romagnoli S, Confalonieri S, Pellegrini C, Serio G, Quarto M, Capra M, Roviaro GC, Contessini Avesani E. Gene expression analysis of early and advanced gastric cancers. Oncogene. 2007;26:4284-4294. [PMID: 17297478 DOI: 10.1038/sj.onc.1210208] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
341 Lee JW, Choi MH, Lee YJ, Ali B, Yoo HM, Song KY, Park CH. Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection. BMC Cancer 2017;17:185. [PMID: 28283024 DOI: 10.1186/s12885-017-3156-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
342 Florou D, Papadopoulos IN, Scorilas A. Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer. Biochem Biophys Res Commun. 2010;391:214-218. [PMID: 19903463 DOI: 10.1016/j.bbrc.2009.11.034] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
343 Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, Roviello F, de Manzoni G, Minicozzi A, Natalini G, De Santis F, Baiocchi L, Coniglio A, Nitti D; Italian Research Group for Gastric Cancer (IRGGC). The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007;245:543-52. [PMID: 17414602 DOI: 10.1097/01.sla.0000250423.43436.e1] [Cited by in Crossref: 254] [Cited by in F6Publishing: 261] [Article Influence: 18.1] [Reference Citation Analysis]
344 Zu H, Wang F, Ma Y, Xue Y. Stage-stratified analysis of prognostic significance of tumor size in patients with gastric cancer. PLoS One 2013;8:e54502. [PMID: 23382906 DOI: 10.1371/journal.pone.0054502] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
345 Hou F, Yuan W, Huang J, Qian L, Chen Z, Ge J, Wu S, Chen J, Wang J, Chen Z. Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients. Med Oncol. 2012;29:2691-2700. [PMID: 22189617 DOI: 10.1007/s12032-011-0127-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
346 Khara HS, Stewart DM, Confer BD, Diehl DL, Johal AS. The role of EUS in missed and known linitis plastica. Endosc Ultrasound 2020;9:202-4. [PMID: 32584317 DOI: 10.4103/eus.eus_20_18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
347 Every AL, Chionh YT, Skene CD, McGuckin MA, Sutton P. Muc1 limits Helicobacter felis binding to gastric epithelial cells but does not limit colonization and gastric pathology following infection. Helicobacter 2008;13:489-93. [PMID: 19166413 DOI: 10.1111/j.1523-5378.2008.00644.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
348 Khosravi Shahi P, Díaz Muñoz de la Espada VM, García Alfonso P, Encina García S, Izarzugaza Perón Y, Arranz Cozar JL, Hernández Marín B, Pérez Manga G. Management of gastric adenocarcinoma. Clin Transl Oncol 2007;9:438-42. [PMID: 17652057 DOI: 10.1007/s12094-007-0082-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
349 Garland SN, Lounsberry J, Pelletier G, Bathe OF. “How do you live without a stomach?”: a multiple case study examination of total gastrectomy for palliation or prophylaxis. Palliat Support Care. 2011;9:305-313. [PMID: 21838951 DOI: 10.1017/s1478951511000253] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
350 Ilhan E, Ureyen O. A Comparison of Subtotal Gastrectomy and Total Gastrectomy for Distal Gastric Cancer. Indian J Surg 2019;81:70-6. [DOI: 10.1007/s12262-018-1834-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
351 Mahar AL, El-Sedfy A, Dixon M, Siddiqui M, Elmi M, Ritter A, Vasilevska-Ristovska J, Jeong Y, Helyer L, Law C, Zagorski B, Coburn NG. Geographic variation in surgical practice patterns and outcomes for resected nonmetastatic gastric cancer in Ontario. Curr Oncol 2018;25:e436-43. [PMID: 30464695 DOI: 10.3747/co.25.3953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
352 Tang K, Liu Y, Dong L, Zhang B, Wang L, Chen J, Chen G, Tang Z. Influence of thermal ablation of hepatic metastases from gastric adenocarcinoma on long-term survival: Systematic review and pooled analysis. Medicine (Baltimore) 2018;97:e13525. [PMID: 30544454 DOI: 10.1097/MD.0000000000013525] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
353 Munday JS, Löhr CV, Kiupel M. Tumors of the Alimentary Tract. In: Meuten DJ, editor. Tumors in Domestic Animals. Hoboken: John Wiley & Sons, Inc.; 2016. pp. 499-601. [DOI: 10.1002/9781119181200.ch13] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 3.2] [Reference Citation Analysis]
354 Hwang SW, Lee DH. Is endoscopic ultrasonography still the modality of choice in preoperative staging of gastric cancer? World J Gastroenterol 2014; 20(38): 13775-13782 [PMID: 25320515 DOI: 10.3748/wjg.v20.i38.13775] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
355 Xu X, Xu L, Gao F, Wang J, Ye J, Zhou M, Zhu Y, Tao L. Identification of a novel gene fusion (BMX-ARHGAP) in gastric cardia adenocarcinoma. Diagn Pathol 2014;9:218. [PMID: 25499959 DOI: 10.1186/s13000-014-0218-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
356 Chia NY, Tan P. Molecular classification of gastric cancer. Ann Oncol. 2016;27:763-769. [PMID: 26861606 DOI: 10.1093/annonc/mdw040] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 14.6] [Reference Citation Analysis]
357 Ji X, Yan Y, Bu ZD, Li ZY, Wu AW, Zhang LH, Wu XJ, Zong XL, Li SX, Shan F, Jia ZY, Ji JF. The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival. BMC Cancer. 2017;17:345. [PMID: 28526077 DOI: 10.1186/s12885-017-3343-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
358 Sun Z, Xu HM. Stage and microscopic positive margins in the treatment of patients with gastric cancer. Ann Surg Oncol. 2010;17:943-945. [PMID: 20039214 DOI: 10.1245/s10434-009-0873-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
359 Labianca R, Sburlati P, Quadri A, Garassino M. Perioperative or postoperative therapy for resectable gastric cancer? Annals of Oncology 2008;19:v99-v102. [DOI: 10.1093/annonc/mdn320] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
360 Konstantoudakis G, Florou D, Mavridis K, Papadopoulos IN, Scorilas A. Kallikrein-related peptidase 13 (KLK13) gene expressional status contributes significantly in the prognosis of primary gastric carcinomas. Clin Biochem. 2010;43:1205-1211. [PMID: 20678496 DOI: 10.1016/j.clinbiochem.2010.07.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
361 Marchet A, Mocellin S, Ambrosi A, de Manzoni G, Di Leo A, Marrelli D, Roviello F, Morgagni P, Saragoni L, Natalini G. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008;34:159-165. [PMID: 17566691 DOI: 10.1016/j.ejso.2007.04.018] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 5.5] [Reference Citation Analysis]
362 Omari J, Drewes R, Orthmer M, Hass P, Pech M, Powerski M. Treatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, interstitial brachytherapy as second-line or salvage therapy. Diagn Interv Radiol 2019;25:360-7. [PMID: 31348004 DOI: 10.5152/dir.2019.18390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
363 Li R, Li J, Wang X, Liang P, Gao J. Detection of gastric cancer and its histological type based on iodine concentration in spectral CT. Cancer Imaging 2018;18:42. [PMID: 30413174 DOI: 10.1186/s40644-018-0176-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
364 Kanda M, Kobayashi D, Tanaka C, Iwata N, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Nomoto S, Murotani K, Fujiwara M, Kodera Y. Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer. Gastric Cancer. 2016;19:255-263. [PMID: 25563579 DOI: 10.1007/s10120-014-0456-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 8.2] [Reference Citation Analysis]
365 Yoo C, Park YS. Companion diagnostics for the targeted therapy of gastric cancer. World J Gastroenterol 2015; 21(39): 10948-10955 [PMID: 26494953 DOI: 10.3748/wjg.v21.i39.10948] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
366 Watkins BJ, Blackmun S, Kuehner ME. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of excluded stomach. Surg Obes Relat Dis. 2007;3:644-647. [PMID: 17950044 DOI: 10.1016/j.soard.2007.06.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
367 Casamayor M, Morlock R, Maeda H, Ajani J. Targeted literature review of the global burden of gastric cancer. Ecancermedicalscience. 2018;12:883. [PMID: 30679950 DOI: 10.3332/ecancer.2018.883] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
368 Costa WL, Coimbra FJ, Fogaroli RC, Ribeiro HS, Diniz AL, Begnami MD, Mello CA, Fanelli MF, Silva MJ, Fregnani JH. Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer center. Radiat Oncol. 2012;7:169. [PMID: 23068190 DOI: 10.1186/1748-717x-7-169] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
369 Zhang H, Sun LL, Meng YL, Song GY, Hu JJ, Lu P, Ji B. Survival trends in gastric cancer patients of Northeast China. World J Gastroenterol 2011; 17(27): 3257-3262 [PMID: 21912476 DOI: 10.3748/wjg.v17.i27.3257] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
370 Kano K, Yamada T, Yamamoto K, Komori K, Watanabe H, Hara K, Shimoda Y, Maezawa Y, Fujikawa H, Aoyama T, Tamagawa H, Yamamoto N, Cho H, Shiozawa M, Yukawa N, Yoshikawa T, Morinaga S, Rino Y, Masuda M, Ogata T, Oshima T. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer. Ann Surg Oncol 2020;27:4235-47. [PMID: 32424582 DOI: 10.1245/s10434-020-08616-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
371 McCall MD, Graham PJ, Bathe OF. Quality of life: A critical outcome for all surgical treatments of gastric cancer. World J Gastroenterol 2016; 22(3): 1101-1113 [PMID: 26811650 DOI: 10.3748/wjg.v22.i3.1101] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
372 Zheng J, Bao WQ, Sheng WQ, Guo L, Zhang HL, Wu LH, Wu XZ. Serum 3'-sulfo-Lea indication of gastric cancer metastasis. Clin Chim Acta 2009;405:119-26. [PMID: 19394320 DOI: 10.1016/j.cca.2009.04.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
373 Cooke CL, Torres J, Solnick JV. Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes. 2013;4:532-540. [PMID: 23851317 DOI: 10.4161/gmic.25720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
374 Peng Z, Wang C, Fang E, Lu X, Wang G, Tong Q. Co-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapy. PLoS One 2014;9:e92924. [PMID: 24675979 DOI: 10.1371/journal.pone.0092924] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
375 Zahalka AH, Frenette PS. Nerves in cancer. Nat Rev Cancer 2020;20:143-57. [PMID: 31974491 DOI: 10.1038/s41568-019-0237-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 56.0] [Reference Citation Analysis]
376 Cheng J, Wang Y, Deng J, McCarthy RJ, Wang G, Wang H, Ye Y. Discrimination of metastatic lymph nodes in patients with gastric carcinoma using diffusion-weighted imaging. J Magn Reson Imaging. 2013;37:1436-1444. [PMID: 23172760 DOI: 10.1002/jmri.23925] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
377 Yie S, Yang H, Ye S, Li K, Dong D, Lin X. Expression of Human Leukocyte Antigen G (HLA-G) Correlates with Poor Prognosis in Gastric Carcinoma. Ann Surg Oncol 2007;14:2721-9. [DOI: 10.1245/s10434-007-9464-y] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 5.0] [Reference Citation Analysis]
378 Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. [Digestive oncology: surgical practices]. J Chir (Paris) 2009;146 Suppl 2:S11-80. [PMID: 19435621 DOI: 10.1016/S0021-7697(09)72398-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
379 Xu L, Wang F, Liu H, Xu XF, Mo WH, Xia YJ, Wan R, Wang XP, Guo CY. Increased expression of cellular repressor of E1A-stimulated gene (CREG) in gastric cancer patients: a mechanism of proliferation and metastasis in cancer. Dig Dis Sci 2011;56:1645-55. [PMID: 21132365 DOI: 10.1007/s10620-010-1510-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
380 Zhu F, Xu C, Jiang Z, Jin M, Wang L, Zeng S, Teng L, Cao J. Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma. Anat Rec (Hoboken). 2010;293:1310-1314. [PMID: 20665809 DOI: 10.1002/ar.21176] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
381 Liu X, Long Z, Cai H, Huang H, Shi Y, Wang Y. Analysis of lymph node metastasis correlation with prognosis in patients with T2 gastric cancer. PLoS One 2014;9:e105112. [PMID: 25136920 DOI: 10.1371/journal.pone.0105112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]